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Resumo 
Os macrófagos são células do sistema imune inato com grande envolvimento na resposta 
inflamatória. A sinalização inflamatória e o metabolismo lipídico estão fortemente 
interligados, pelo que a caracterização das alterações lipídicas que acompanham o espetro 
fenotípico e funcional dos macrófagos é especialmente relevante. Vários flavonoides são 
conhecidos pela sua atividade anti-inflamatória, no entanto, pouco se sabe acerca do seu efeito 
na composição e metabolismo lipídicos. Neste trabalho, utilizámos uma abordagem lipidómica 
baseada na análise por cromatografia líquida acoplada a espetrometria de massa (LC-MS) de 
extratos celulares lipídicos, para caracterizar as alterações no fosfolipidoma de macrófagos 
humanos (diferenciados a partir de monócitos THP-1) em resposta a três flavonoides: 
quercetina (Que), naringina (Nar) e naringenina (Ngn). Para efeitos de comparação, foram 
ainda analisados macrófagos estimulados com LPS/IFN-γ (M1) e IL-4/IL-13 (M2). Este 
estudo permitiu a identificação de 147 fosfolípidos pertencentes a 8 classes diferentes: 
fosfatidilcolinas (PC), fosfatidiletanolaminas (PE), lisofosfatidilcolinas (LPC), 
lisofosfatidiletanolaminas (LPE), fosfatidilgliceróis (PG), fosfatidilinositóis (PI), 
fosfatidilserinas (PS) e esfingomielinas (SM). Todos os flavonoides tiveram um impacto 
pronunciado no fosfolipidoma dos macrófagos, provocando variações de grande magnitude 
em 47-76% de todas as espécies identificadas. Comparando os efeitos mais proeminentes em 
macrófagos pré-polarizados para M1, verificou-se que a remodelação lipídica induzida pelos 
flavonoides incluiu aumentos em espécies de LPC, LPE e PG, e diminuições em espécies de 
SM e plasmalogénios de colina, ao passo que a modulação das outras classes de PL foi 
claramente diferente para cada flavonoide. No geral, o maior grau de semelhança nos efeitos 
produzidos foi visto entre a quercetina e a naringenina. Embora não podendo atribuir variações 
individuais a funções biológicas específicas, foi possível concluir que os três flavonoides 
afetaram a composição e propriedades das membranas, a sinalização e comunicação celulares 
e, possivelmente, a atividade antioxidante. Interessantemente, duas espécies emergiram como 
potenciais marcadores lipídicos da ação anti-inflamatória mediada por flavonoides: PC(32:0) e 
PE(O-36:6)/PE(P:36:5), decrescendo ambas em resposta à polarização M2 e a qualquer um 
dos flavonoides. A sua atividade anti-inflamatória e a sua relevância para aspetos da biologia 
dos macrófagos (por ex., fluidez membranar, produção de citocinas, capacidade fagocítica) 
deverão ser investigadas em estudos futuros. Em suma, este trabalho demonstrou que o 
fosfolipidoma de macrófagos humanos é extremamente sensível ao tratamento com 
flavonoides, abrindo novas perspetivas de investigação rumo a uma melhor compreensão da 
interligação entre a modulação lipídica mediada por flavonoides e a resposta inflamatória dos 
macrófagos. 
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Abstract  
Macrophages are innate immune cells deeply involved in inflammation. Inflammatory 
signalling and macrophage lipid composition are closely related, underlying the relevance of 
characterising lipid alterations accompanying macrophage phenotypic and functional 
spectrum. Several flavonoids are recognized for their anti-inflammatory activity, although 
little is known about their effects towards macrophage lipid composition and metabolism. In 
this work, we have employed a lipidomics approach based on liquid chromatography-mass 
spectrometry (LC-MS) analysis of cellular lipid extracts to characterize the alterations in the 
phospholipidome of human macrophages (differentiated from THP-1 monocytes) in response 
to three flavonoids: quercetin (Que), naringin (Nar) and naringenin (Ngn). Macrophages 
stimulated with LPS/IFN-γ (M1) and IL-4/IL-13 (M2) were also profiled for comparison. This 
study enabled the identification and relative quantification of 147 phospholipids (PL) 
belonging to 8 different classes: phosphatidylcholines (PC), phosphatidylethanolamines (PE), 
lysophosphatidylcholines (LPC), lysophosphatidylethanolamines (LPE), 
phosphatidylglycerols (PG), phosphatidylinositols (PI), phosphatidylserines (PS) and 
sphingomyelins (SM).  All flavonoids were seen to have a pronounced impact on the 
macrophage phospholipidome, causing large magnitude variations in 47-76% of all identified 
PL species. By comparing the most prominent effects of the three flavonoids on M1 pre-
polarized macrophages, it was found that flavonoid-mediated lipid remodelling was generally 
characterized by increases in LPC, LPE and PG species, accompanied by decreases in choline 
plasmalogens and SM species, whereas the modulation of other PL species was clearly 
flavonoid-dependent. Overall, quercetin and naringenin shared the greatest similarity. 
Although it was not possible to attribute individual variations to specific biological functions, 
it could be concluded that flavonoids affected cell membrane composition and properties, cell 
signalling and communication, and, possibly, antioxidant activity. Interestingly, two species 
emerged as potential anti-inflammatory lipid markers of flavonoid activity, PC(32:0) and 
PE(O-36:6)/PE(P-36:5), decreasing in response to either M2 polarization and flavonoid 
treatment. Their anti-inflammatory activity and relevance to macrophage biology (e.g., 
membrane fluidity, production of cytokines, phagocytic capacity) should be explored in future 
studies. Overall, this work has shown that human macrophage phospholipidome is exquisitely 
sensitive to flavonoid treatment, opening new research perspectives towards a greater 
understanding of the interplay between flavonoid-induced PL modulation and macrophage 
inflammatory responses.  
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I.1. Macrophage polarization in inflammation 
Inflammation is a complex physiological response to potentially harmful stimuli, such 
as pathogens, external injuries (e.g. incisions, foreign bodies), toxicants or irritants, playing a 
protective role to promote the return to homeostasis [1]. The initial phase in inflammation 
involves plasma proteins and multiple cells, such as circulating leucocytes and tissue 
phagocytes, which recognize damage-associated molecular patterns (DAMP) and pathogen-
associated molecular patterns (PAMP), and become activated, releasing a panoply of 
inflammatory mediators. After the rapid initial onset, the acute inflammatory response 
typically lasts from hours to a few days, being closely intertwined with repair of damaged 
tissue. However, inflammation can also be prolonged in time, resulting in a chronic state with 
harmful consequences. Indeed, it is currently recognized that chronic inflammation is 
implicated in the pathogenesis of multiple diseases, such as cancer, atherosclerosis and 
neurodegenerative diseases [2]. Unresolved inflammatory response is also involved in the 
rejection of transplant organs and medical implants, compromising their successful integration 
and function [3]. Therefore, finding novel approaches to promote appropriate control and 
resolution of inflammation is of utmost importance. 
Macrophages are myeloid cells of the innate immune system, which reside in most 
tissues and are part of the mononuclear phagocyte system [4,5]. They first appear in the yolk 
sac and seed several tissues during embryonic development [6], maintaining their population 
through self-renewal [7]. Macrophages may also arise from differentiation of blood monocytes 
[5]. Monocytes are a type of leucocytes, produced in the bone marrow and released into the 
circulatory system, where they can remain for one to three days. During inflammation, 
monocytes from the bloodstream are recruited to the inflamed tissue site by different stimuli, 
such as C-C motif chemokine ligand 1 (CCL1) or CCL5, through a process called chemotaxis 
[8]. Upon this stimulation, when monocytes reach the tissue, they differentiate into 
macrophages, a process which involves a set of changes in their morphology, such as: 
reduction of the nucleocytoplasmatic ratio, due to an increase of the cytoplasmatic volume [9]; 
enhancement of granularity [10]; and accumulation of lysosomes and mitochondria [11]. 
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Macrophages are heavily involved in all stages of inflammation, mainly through three 
main functions: phagocytosis, which allows clearance of pathogens and foreign invaders 
perceived as threats; antigen presenting activity, linking innate to adaptive immunity; and 
production of inflammatory mediators (such as cytokines and growth factors), which are 
critical for both the onset and resolution of an inflammatory reaction [1,12]. Due to their 
different functions, distribution and response to stimuli, macrophages display high 
heterogeneity and plasticity, which are crucial for their protective role and the outcome of the 
inflammatory response. When in contact with different microenvironmental stimuli, 
macrophages acquire different phenotypes through a process called activation or polarization 
[13]. In simplified terms, the extremes of the phenotypic spectrum can be designated as pro-
inflammatory or classically activated (M1) macrophages, and as anti-inflammatory or 
alternatively activated (M2) macrophages. M2 macrophages are usually further subdivided 
into M2a, M2b, M2c and M2d subsets, depending on the main stimuli present (Figure 1) [14]. 
Macrophages subsets display distinct gene expression profiles which translate into different 
functional attributes. In general, M1 macrophages are characterized by increased phagocytic 
activity and pro-inflammatory cytokines production, while M2 macrophages are responsible 
for tissue repair, inflammation resolution and production of anti-inflammatory cytokines. 
Inadequate balance of these populations during the inflammatory response may lead to 
prolonged and harmful inflammation. Therefore, timely and adequate modulation of 
macrophage polarization is considered to be an attractive goal in various medical contexts, 
including treatment of diseases [15] and regenerative medicine [3,16]. 
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I.1.1. Classically activated macrophages (M1) 
M1-like macrophages are responsible for phagocytosing foreign invaders and display 
antigen presenting activity. These macrophages are associated with Th1-mediated pathologies, 
and tend to promote inflammation. Additionally, M1-like macrophages display a protective 
role against cancer, through clearance of tumor cells [17].  
Steady state, or resting, macrophages (M0) may polarize into M1-like macrophages 
when in contact with i) molecular patterns associated with microbial infection, such as 
lipopolysaccharides (LPS), or other agonists of Toll-like receptors (TLR), such as free fatty 
acids, oxidized lipoproteins and high-mobility group protein 1, or ii) pro-inflammatory 
cytokines, such as tumor-necrosis factor-α (TNF-α), interferon-γ (IFN-γ), among others [18]. 
Such stimulation leads to induction of several pathways that culminate in the activation of 
different transcription factors, such as nuclear factor kappa B (NF-κB) or interferon regulatory 
Figure 1 – Activation (or polarization) of macrophages. Blood circulating monocytes are recruited to 
inflammation site, and penetrate tissue. Monocytes differentiate into steady state macrophages (M0). When in 
contact with different stimuli macrophages acquire different phenotypes (M1, M2a, M2b, M2c or M2d). 
Legend: LPS – lipopolysaccharide; IFN-γ – interferon-γ; TNF-α – tumor necrosis factor α; TLR – Toll-like 
receptors; IL-4 – interleukin 4; IL-13 - interleukin 13; IL-1-R – interleukin 1 receptor; IL-10 – interleukin 10; 
TGF-β – tumor growth factor β; IL-6 – interleukin 6. Adapted from Weagel et al [14]. 
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factors (IRF). Another important factor that enhances pro-inflammatory expression in M1-like 
macrophages is the activation of inflammasomes, more precisely, NLRP3 (nucleotide-binding 
oligomerization domain-like receptor protein-3) inflammasome. Inflammasomes are 
intracellular multi-protein signalling complexes involved in the activation of inflammatory 
caspases. When macrophages are M1-stimulated, they increase their ROS (reactive oxygen 
species) production, which promotes NLRP3 inflammasome activation [19–21]. Activation of 
NLRP3 inflammasome stimulates caspase-1 which will further cleave the precursor of 
interleukin-1β (pro-IL-1β), boosting the production of pro-inflammatory IL-1β [22,23]. 
 Several molecules have been highlighted as markers of M1-like polarization including 
cell surface receptors, cytokines and chemokines, which are small signalling proteins involved 
in the immune response, in addition to other factors like enzymes and small molecules (Table 
1) [24–26]. Some of the surface receptors typically expressed in M1-like macrophages are: 
cluster of differentiation 80 (CD80), adenosine receptor 2A (A2AR), A2BR, CD64, and 
human leukocyte antigen – antigen D related (HLA-DR), as well as different recognition 
patterns, such as TLR and Nod-like receptors (NLR) [18,24–26]. M1-like macrophages are 
also characterized by their increased production of pro-inflammatory cytokines, such as IL-6, 
IL-12, IL-1β, TNF-α and others. Additionally, M1-like macrophages secrete high levels of 
some chemokines, such as CXCL8 (chemokine C-X-C motif ligand 8), CXCL11 and CCL5 
(chemokine C-C motif ligand 5) [27]. Other molecules reported to be upregulated in M1 
macrophages include nitric oxide (NO) synthase (iNOS), cyclooxygenase-2 (COX-2), vascular 
endothelial factor (VEGF), fibroblast growth factor 2 (FGF2), as well as some oxidative 
metabolites, such as NO and ROS [18,24–26]. 
 It should be noted that some of these markers are dependent on the species considered. 
For instance, iNOS, VEGF, FGF2 and HLA-DR are only upregulated in murine M1-like 
macrophages, not in human M1-like macrophages [12], as indicated in Table 1. 
I.1.2. Alternatively activated macrophages (M2) 
M2-like macrophages participate in tissue repair and remodelling, as well as in 
resolution of inflammation [14]. Additionally, these macrophages are responsible for 
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maintaining homeostasis in adipose tissue and mediate the immune response to helminth 
parasites.  
Depending on the polarization stimuli, several M2-like polarization phenotypes have 
been identified, namely M2a, M2b, M2c and M2d phenotypes [28–30]. M2a macrophages 
arise from interaction with IL-4, IL-13, and fungal or helminth infections, and are involved 
with Th2 immune response, type 2 inflammation and clearance of parasites [14]. The M2b 
subtype is elicited by IL-1 receptor agonists and immune complexes, and is involved in 
metastasis control and Th1 immune response, being capable of supressing tumour growth [14]. 
The M2c-like phenotype is acquired through stimulation with IL-10, TGF-β and 
glucocorticoids [28,29], and is associated with tissue repair and remodelling, matrix deposition 
and immunoregulation [14]. These three subtypes often display an anti-inflammatory cytokine 
profile characterized by low production of IL-12 and high production of IL-10 [29]. The 
fourth M2 subtype described is M2d, which seems to be elicited by IL-6 and adenosine, and 
displays features of tumour-associated macrophages, promoting angiogenesis [14,30]. 
However, along this thesis, we will be mostly referring to M2 macrophages in general without 
distinguishing M2 subtypes. 
Different pathways are involved in M2-like polarization, mainly, Janus kinase–signal 
transducer and activator transporter (JAK-STAT) pathways that activate STAT6. This 
transcription factor promotes the expression of several genes involved in M2-like macrophage 
functions [31], often recognized as M2 markers (listed in Table 1). Some of them are surface 
receptors, and mediate interactions with environment, such as mannose receptor C-type 1 
(MRC-1), dectin-1, dendritic cell-specific intercellular adhesion molecule-3-grabbing non-
integrin (DC-SIGN), CD36, macrophage receptor with collagenous structure (MARCO), 
CD163, scavenger receptor A1 (SR-A1), SR-B1, lectin-like oxidized low-density lipoprotein 
(LDL) receptor-1 (LOX-1), A1R, and A3R [18,24–26]. M2-like macrophages also display an 
increased set of cytokines with an anti-inflammatory role, such as IL-4, IL-10 and resistin-like 
α (FIZZ1 or RETNL-α). Additionally, some chemokines are increased in M2-like 
macrophages (CCL16, CCL17, CCL22), as well as some other molecules, like arginase-1, 
fibronectin, spermine and chitinase-like 3 (Ym1 or CHIL-3). Similar to M1-like macrophages, 
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murine and human M2-like macrophages display some important differences in gene and 
protein expression; for example, CHIL-3, FIZZ1 and arginase-1 seem to have no human 
homologous [32], and are often disregarded as polarization markers for human M2-like 
macrophages. 
 
Table 1 - Common macrophage polarization markers. 
 Note: Expressed markers vary with polarization stimuli and macrophage’s species. 
*only found in murine macrophages. 
 
 
I.2. Lipid composition and metabolism in M1/M2 polarized macrophages 
Lipids are a diverse group of biological macromolecules which have many key 
biological functions, such as acting as structural components, serving as energy storages, and 
being involved in signalling pathways [34]. Lipids are also crucially important in 
inflammation [35]. Some lipid species are described to have a pro-inflammatory role, e.g. by 
Class type Markers 
Macrophage 
Phenotype 
References 
Surface 
Receptors 
CCR7, CD80, A2AR, A2BR, CD64, HLA-DR M1 [24–26] 
CCR2, CXCR1, CXCR2, MRC-1, dectin-1, DC-
SIGN (or CD209), CD36, MARCO, CD206, 
CD163, SR-B1, SR-A1, LOX1*, A1R, A3R 
M2 [24–26] 
Cytokines 
IL-1, IL-6, IL-12, IL-18, IL-23, IL-1β, TNF-α M1 [12,24,33] 
IL-4, FIZZ1*, IL-10, IL-1RA, sIL-1R M2 [24,31] 
Chemokines 
 
CXCL8, CXCL9, CXCL10, CXCL11, CXCL16, 
CCL2, CCL3, CCL4, CCL5 
M1 [25] 
CCL1, CCL16, CCL17, CCL18, CCL22, CCL24 M2 [25] 
Others 
Spermine, NO, O2-, iNOS*, COX-2, VEGF*, 
FGF2* 
M1 [24–26] 
CHIL3*, PGC-1β, arginase-1* M2 [24–26] 
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acting as precursors of pro-inflammatory mediators (e.g. prostaglandins), while other display 
anti-inflammatory activity contributing for resolution of inflammation. 
In the context of macrophage polarization, there has been growing interest in assessing 
how macrophages change their lipid composition and metabolism in response to different 
stimuli. Most data reported so far focused on the changes induced by canonical M1 and M2 
stimuli, as an attempt to deepen current understanding of the molecular biology underlying 
macrophage plasticity. These data are summarized along the next sections, considering some 
major lipid classes: fatty acids (FA), acylglycerols, glycerophospholipids, sphingolipids, 
eicosanoids and sterols [34]. 
I.2.1. Fatty acids  
Fatty acids (FA) are carboxylic acids with long aliphatic chains that can either be 
saturated or unsaturated [34]. They can arise from endogenous synthesis, where they are 
formed through elongation of an acetyl-CoA primer with malonyl-CoA, or they can be 
obtained from diet [36]. These free fatty acids (FFA) are often incorporated in reserve lipids, 
such as triglycerides, where they are stored as an energy source. When this source of energy is 
required, FA are released and degraded through β-oxidation (FAO). FA can also be 
incorporated in structural lipids, such as phospholipids (PL), where they display an important 
function in maintaining membrane’s structure and fluidity. Additionally, FA can be used as 
precursors for the biosynthesis of signalling molecules, such as prostaglandins (PTG). Due to 
their different roles in energy storage, structure and fluidity of membrane and cell signalling, 
FA are considered a fundamental class of lipids for homeostasis of all cells, including 
macrophages.  
When macrophages acquire a M1-like phenotype, they typically display increased FA 
synthesis [37]. This upregulation results from increased expression and activity of several 
enzymes, as well as an increased substrate availability, both being essential for the expression 
of the pro-inflammatory profile [37–43]. The increase in substrate availability arises from 
downregulation of isocitrate dehydrogenase in M1-like macrophages, resulting in citrate 
accumulation that can be diverted for anabolic purposes [43]. Export of citrate from the 
mitochondria is driven by increased expression of mitochondrial citrate carrier in M1-like 
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macrophages [44]. Once in the cytoplasm, ATP-citrate lyase converts citrate back to 
oxaloacetate and acetyl-CoA, allowing the latter to be used for FA synthesis [45]. Another 
substrate involved in FA synthesis is NADPH, generated through the pentose phosphate 
pathway (PPP), which is upregulated in M1 macrophages. Activation of this pathway is 
mediated by an increase in glucose uptake and downregulation of carbohydrate kinase-like 
protein (CARKL) [42]. Increase in both citrate and NADPH support the increase in FA 
synthesis observed in M1-like macrophages. This FA synthesis is mediated, mainly, by two 
enzymes, acetyl-CoA carboxylase (ACC) and FA synthase (FASN), which are upregulated in 
M1-like macrophages [37,38]. In particular, murine bone marrow-derived macrophages 
(BMDM) stimulated with LPS, a M1-prototypical stimulus, have been reported to display 
higher expression (and activity) of both ACC and FASN, which has been correlated with 
increased FA synthesis [37,38]. Moreover, FASN activation was reported to be important for 
pro-inflammatory activity of M1-like macrophages through activation of caspase-1 mediated 
by NLRP3 inflammasome [37]. Specifically, uncoupling protein 2 (UCP-2) expression was 
tightly correlated with FASN expression. Inhibition of UCP-2 in M1 macrophages resulted in 
downregulation of FASN, associated with a reduced TG synthesis and reduced NLRP3-
mediated caspase-1 activation. On the other hand, a more recent study has shown FASN 
upregulation in LPS-stimulated murine BMDM to be associated with an increase in 
phosphorylation of c-Jun N-terminal kinase (JNK), suggesting that M1-like polarization 
induces upregulation of FASN through this pathway [38]. Moreover, inhibition of FASN 
resulted in changes in labile detergent-resistant microdomains (DRM) content, suggesting that 
newly synthesized lipids are channelled to DRM, in M1 macrophages. FASN is also a target 
of hypoxia-inducible factor 1α, which has been described as a major transcriptional modulator 
of M1-like polarization [46].  
Most newly synthesized FA species require additional steps of elongation and 
desaturation giving rise to monounsaturated FA (MUFA) [47]. Desaturation of FA is catalysed 
by stearoyl-CoA desaturases (SCD), such as SCD1 and SCD2, while specific FA elongases 
are responsible for FA elongation. SCD1 was found to be upregulated in M1-polarized 
peritoneal macrophages and J774 cells, a commercial cell line [48,49]. Moreover, upregulation 
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of SCD1 in these macrophages resulted in inhibition of ATP-binding cassette transporter 
protein A1 (ABCA1) [48,49], a cholesterol efflux protein responsible for regulating 
cholesterol levels, typical of M2-like macrophages [50]. This inhibition of ABCA1 led to 
accumulation of cholesterol in these macrophages [48,49]. M1 murine BMDM also displayed 
an increase in elongation of very long chain FA protein 6 (ELOVL6) [51,52]. ELOVL6 is 
responsible for elongation of C16 and C18 FA. Inhibition of ELOVL6 in murine macrophages 
seems to be associated with alterations in FA profile of cholesterol esters, as well as 
cholesterol accumulation [51].  
In addition to de novo synthesis, FA can arise from exogenous sources [53]. Uptake of 
FA is regulated by FA transport proteins residing in the cytoplasmic membrane. It was 
reported that M1 murine primary macrophages displayed upregulation of adipocyte-fatty acid-
binding protein aP2 (aP2) [39]. aP2 is involved in fatty acid uptake and is highly expressed by 
adipocytes. Blocking aP2 resulted in reduction of TNF-α secretion, a cytokine highly 
produced by M1-like macrophages. This suggests the importance of aP2 as a pro-
inflammatory mediator in these cells. Inhibition of aP2 additionally decreased total cholesterol 
and cholesterol ester, while increasing cellular triglycerides (TG) and FFA contents.  
On the other hand, M2-like polarization has been proposed to be characterized by an 
increase in FAO [54]. In this process, fatty acids are broken down into acetyl-CoA, which can 
be further used to produce energy through the tricarboxylic acid (TCA) cycle and oxidative 
phosphorylation (OXPHOS) [36]. In eukaryotic cells, FAO takes place mainly in the 
mitochondria, and requires FA transport through the mitochondrial membrane, which occurs 
via conjugation with carnitine. Carnitine palmitoyltransferase 1A (CPT1A), CPT2 and 
carnitine acetyltransferase (CrAT) are responsible for carnitine conjugated FA transport, and 
seem to play a role in M2-like macrophages. Indeed, these proteins were found to be 
upregulated in macrophages stimulated with IL-4, a prototypical M2 polarization stimulus 
[31,55–57]. Upregulation of CPT1A was reported to occur through activation of peroxisome-
proliferator activator receptor α (PPARα) and PPARδ, upon M2- polarization. Additionally, 
several enzymes involved in FAO were found upregulated in M2-like macrophages 
[31,54,58]. Vats et al detected an increase in mRNA from enzymes involved in FAO, namely, 
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acyl-CoA dehydrogenase, enoyl-CoA hydratase and CPT1 [31] in macrophage exposed to IL-
4, which was associated with an increase in PGC-1β activity. Upregulation of enzymes 
involved in FAO has been proposed to  result from activation of the STAT6 pathway [59]. 
Upon M2-like polarization, STAT6 is activated and enhances PPARγ and PPARγ-coactivator-
1β (PGC-1β), which further promotes transcription of FAO-related proteins.  
However, some recent works have questioned the requirement for FAO in M2 
polarization, especially in human macrophages [57,60,61]. Indeed, FAO inhibition with 
etomoxir had no effect on gene expression of IL-4-stimulated macrophages, showing that this 
pathway was not essential for M2 activation. Hence, the association between FAO and the M2 
phenotype might be more complex that initially thought. 
Oxidation of fatty acids can also occur in peroxisomes, namely to degrade very-long-
chain FA (VLCFA), branched-chain FA (BCFA) and polyunsaturated FA (PUFA) [62]. 
BMDM and peritoneal M2-like macrophages have been reported to display  increased 
expression of acyl-CoA oxidase 1 (ACOX1), an enzyme involved in peroxisomal β-oxidation 
[63]. On the other hand, compared to unstimulated (M0) macrophages, the levels of enoil-CoA 
hydratase/3-hidroxiacyl-CoA dehydrogenase (EHHCAD) in M2 macrophages were neither 
increased nor reduced. However, there was a strong downregulation of these enzymes in LPS-
stimulated macrophages, suggesting its possible pro-resolving role. 
FA can either arise from exogenous sources, with uptake from membrane transporters 
[58,64], or they can be released from endogenous storage [54,65]. M2-polarized BMDM were 
reported to display an upregulation in fatty acid transporter protein 1 (FATP1) [58], a 
membrane protein involved in the uptake of long-chain fatty acids, suggesting upregulated FA 
uptake from exogenous sources. Additionally, mRNA levels of FATP4 were also upregulated 
in M2 macrophages. On the other hand, when macrophages acquired the M1-like phenotype, 
FATP1 was downregulated, compared to basal levels, whereas FATP1 overexpression resulted 
in attenuation of inflammation. This supports the importance of FA uptake to the anti-
inflammatory activity of M2-like macrophages, although this could be species-dependent.  
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I.2.2. Acylglycerols 
Acylglycerols (or glycerolipids) are a class of lipid species composed of mono-, di-, or 
tri-substituted glycerols [66]. TG are the most well-known acylglycerols, acting as an energy 
storage. Through lipolysis, the esterified FA are released and can be used. Adipose triglyceride 
lipase (ATGL) and hormone-sensitive lipase (HSL) have been reported to be upregulated in 
murine M1-polarized BMDM, compared to M2-polarized macrophages [40]. Both lipases are 
responsible for the release of FA from TG, making FA available to be used by cells. ATGL 
inhibition resulted in reduction of the pro-inflammatory cytokine IL-6, reflecting the role of 
ATGL as a pro-inflammatory mediator in M1-like macrophages.  
In another study of LPS-stimulated BMDM, transcriptomic data revealed the 
upregulation of some enzymes involved in TG synthesis, including aldehyde dehydrogenase 1 
family member B1, 1-acyl-glycerol 3-phosphate O-acyltransferase 4 and diacylglycerol O-
acyltransferase 1 and 2 [67]. Additionally, this study explored lipidomic changes in TG 
species upon M1-like polarization, having found increases in several TG, such as TG (50:1), 
TG (53:2), TG(54:4), TG(54:6), TG(56:4) and TG(58:6). Another study also found the TG 
content to be increased upon M1 polarization, compared to unstimulated (M0) and M2-
polarized macrophages [54]. Some of the TG species, detected through mass spectrometry, 
found to be increased in M1 macrophages were: TG(50:1), TG(52:2), TG(54:1) and TG(54:2).  
Increased lipolysis (i.e. the breakdown of TG into FFA and glycerol) has also been 
suggested to characterize M2-like macrophages [54]. In particular, BMDM and M2 murine 
peritoneal macrophages stimulated with IL-4 and exposed to very-low density lipoproteins 
(VLDL) displayed enhanced lipolysis in association with increased expression of lipoprotein 
lipase (LPL). This enzyme was proposed to regulate FA uptake from exogenous sources by 
acting as a rate-limiting enzyme in lipolysis of exogenous lipoproteins. Lysosomal lipase 
(LAL), which is another enzyme involved in the release of FA from exogenous sources, was 
also highly expressed in IL-4-polarized macrophages [54]. In fact, upregulation of LAL 
appeared to be important for the role of these macrophages resolving inflammation, as 
inhibition of LAL resulted in exacerbation of inflammation, as well as in increased lipid body 
formation [54]. In correlation with this increased lipolysis, extracellular levels of glycerol 
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were also increased, and so were the levels of some monoacylglycerol species, namely 1-
oleoglycerol, 1-stearoylglycerol, 1-palmitoylglycerol, and 2-palmitoylglycerol [54].  
I.2.3. Glycerophospholipids 
Glycerophospholipids are a class of lipids with a polar head (containing a phosphate 
group) and two hydrophobic tails (consisting of two fatty acids), which are crucially  
important for cell homeostasis [68]. Due to their amphiphilic nature, phospholipids can form 
bilayers, which makes them the major component of cell membranes. These lipids can also be 
involved in cell signalling, and play an important role in inflammation, namely through release 
of arachidonic acid (AA) that will be further converted in PTG [69–71]. Due to their 
involvement in inflammation, specifically regarding PTG production, phospholipids play an 
important role in macrophages. 
The metabolism of phospholipids in differentially polarized macrophages has been 
explored by some researchers [70–73]. In LPS-stimulated Raw 264.7 macrophages (M1), there 
was an increase in mRNA levels of several enzymes involved in phospholipid biosynthesis, 
namely 1-acylglycerol-3-phosphate O-acyltransferase 4, phospholipid phosphatase 1, cytidine 
5-diphosphate-diacylglycerol-inositol 3-phosphatidyltransferase, phospholipase D1 and 
phosphatidylserine decarboxylase [73]. Concomitantly, some phospholipid species were also 
increased, compared to resting macrophages (M0), namely molecular species belonging to 
different phospholipid classes: phosphatidylcholine (PC), phosphatidylserine (PS), 
phosphatidylglycerol (PG) and phosphatidylethanolamine (PE); however, the exact identities 
of such species were not detailed in this study. Additionally, some diacyl-glycerol and 
phosphatidic acid (PA) species (32:0, 34:0, 34:1, 36:0 and 36:1) were increased as well.  
Changes in phospholipase A2 enzymes, responsible for the release of AA (used to 
produce PTG), have also been reported in association with macrophage polarization [70–72].  
These enzymes can be classified as cytosolic phospholipase (cPLA2) and secreted 
phospholipase (sPLA2). cPLA2, also referred to as Group IV phospholipase A2, has been 
found upregulated in M1-polarized macrophages [70]. Induction of cPLA2 seems to occur in a 
TLR-dependent manner, as a result of LPS-induced polarization stimulus [71]. Increase in 
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cPLA2 levels was accompanied by an increase in the release of AA [70]. On the other hand, 
M2-like polarization has been associated with an increase in sPLA2 levels, also referred as 
Group V phospholipase A2 [72]. Such upregulation was not observed in M1-like 
macrophages. Additionally, sPLA2 displayed a preference for hydrolysis of PE species, which 
was detected by an increase in LPE species.  
I.2.4. Sphingolipids  
Sphingolipids are a class of lipid species with a sphingoid base as their backbone, and 
are involved in cell signalling and recognition [74]. Based on their structure, sphingolipids can 
be classified as simple (e.g. ceramides), or complex (e.g. cerebrosides). Some studies have 
suggested an integral role for sphingolipids in inflammation [75]. In particular, some species, 
like ceramide, ceramide-1-phosphate and sphingosine-1-phosphate, were found to promote 
activation of pro-inflammatory factors and induction of COX-2, further resulting in pro-
inflammatory PTG production. 
Raw 264.7 macrophages have been reported to increase their de novo synthesis of 
sphingolipids, upon activation with Kdo2-Lipid A (KLA) [76]. Furthermore, mRNA levels of 
several enzymes involved in sphingolipids biosynthesis were increased, namely, serine 
palmitoyltransferase (Sptl1 and Sptc2), ceramide synthase 4, sphingosine kinase 1, 
sphingosine kinase 2, sphingosine-1-phosphate lyase, and sphingolipid-1 Δ-4-desaturase [73]. 
Despite the increase in mRNA levels, evaluation of protein levels or activity of these enzymes 
has not been explored yet.  
I.2.5. Eicosanoids 
Eicosanoids are 20-carbon lipid species derived from AA, which are heavily involved 
in the regulation of inflammation [77]. When AA is released from phospholipids it can enter 
different pathways - cyclooxygenase, lipoxygenase, and cytochrome P450 - that will result in 
the synthesis of different subtypes of eicosanoids, such as PTG, thromboxanes (TX), or 
leukotrienes (LT). Some enzymes are responsible for synthesis of these eicosanoids, namely, 
COX1, COX-2 and several lipoxygenases. Therefore, changes in the expression and/or activity 
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of these enzymes in M1 and M2 macrophages give interesting insights into the role of 
eicosanoid metabolism in macrophage polarization. 
Up-regulation of COX-2 has been identified as a crucial hallmark of LPS/IFN-γ (M1) 
macrophage polarization [78]. Up-regulation of COX-2 in M1 macrophages was accompanied 
by an increased activity, resulting in increased PGE2 production [69]. Additionally, TXB2 
production was also increased. Such increase in these eicosanoid species in M1-polarized 
macrophages, compared to M2-polarized macrophages, might suggest a different pattern of 
eicosanoid synthesis. Some lipidomic studies have unravelled the eicosanoids profile of M1 
macrophages [58,67]. Through liquid chromatography-mass spectrometry (LC-MS), Johnson 
and colleagues found an increase in PGD2, PGE2 and TXB2, in M1 macrophages stimulated 
with LPS [58]. In a different study, other eicosanoids were found to be increased in M1 
macrophages: PGD2, PGE2, PGF2a, PGJ2, dPGD2, dPGJ2 (15-deoxy PGJ2), TXB2, 12-
eicosatetraenoic acid (12-HETE), 17-HETE, 18-HETE, and 19-HETE. On the other hand, M2-
like macrophages were reported to display an upregulation in COX-1 activity [79]. However, 
PGE2 and TXB2 were not increased in M2-like macrophages. Interestingly, there was an 
increase in dPGJ2, in these macrophages.  
I.2.6. Sterols 
Sterols are a group of amphipathic lipid molecules, with cholesterol being the most 
well-known sterol. Cholesterol has well known functions as a mediator to maintain membrane 
fluidity, and as a precursor for the synthesis of hormones [80]. Macrophages control their 
cholesterol levels through surface receptors that are capable of taking up cholesterol (in the 
form of lipoproteins), as well as through efflux proteins and of cholesterol biosynthesis 
[26,50,54,58,67].  
Upon M1 polarization of BMDM macrophages, some enzymes involved in cholesterol 
biosynthesis have been reported to be downregulated, including  lanosterol synthase, 
lanosterol 14a demethylase (CYP51A1) and hydroxysteroid 17-β-dehydrogenase 7 [67]. On 
the other hand, 3-hydroxy-3-methylglutaryl-coenzyme A reductase was upregulated in M1-
like macrophages, and so were the levels of desmosterol [67]. These results are in line with 
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another study, which evaluated mRNA levels of enzymes involved in sterol biosynthesis, 
using Raw 264.7 M1-polarized macrophages [73], where mRNA levels of these enzymes were 
also decreased. Furthermore, cholesterol 25-hydroxylase mRNA levels were increased. Still, 
along with desmosterol, lanosterol was reported to be increased in M1-like macrophages 
[58,67]. There was also an increase in several products of the cholesterol biosynthesis 
pathway. 
M2 macrophages display an upregulation in surface scavenger receptors, and are often 
identified by some of those receptors, such as CD36, LOX1 and SR-A1 [26]. These receptors 
are involved in the uptake of oxidized circulating LDL (oxLDL). An increase in these 
receptors would suggest an increase in the uptake of oxLDL, related with foam cell formation 
[81,82]. This would suggest the involvement of M2-like macrophages in foam cell formation. 
However, when M2-like macrophages acquire their phenotype, there is an increase cholesterol 
efflux proteins, such as ABCA1 [50], which is responsible for the efflux of oxLDL, avoiding 
oxLDL accumulation, and ABCG1, SR-B1 and 27-hydroxylase (responsible for cholesterol 
efflux) [26]. Furthermore, cholesterol esters were found decreased in M2-like macrophages 
[54,64], with some species being notably decreased: CE16:0, CE16:1, CE18:1 and CE18:2 
[54]. 
Summarizing, M1-like macrophages seem to rely on lipid biosynthesis, specifically 
though increase in FA synthesis, sphingolipid biosynthesis and production of eicosanoids with 
pro-inflammatory properties. On the other hand, M2-like macrophages are characterized by 
increased FAO and synthesis of anti-inflammatory eicosanoids. Additionally, polarization 
seems to induce changes in membrane composition and glycerophospholipid content, that 
differ between M1-like and M2-like phenotypes. A few of these glycerophospholipid species 
were described as possible activation state biomarkers for human macrophages. 
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I.3. Anti-inflammatory potential of modulating macrophage lipid metabolism 
The modulation of macrophage lipid composition and metabolism upon activation 
raises the question as to whether targeting enzymes or regulators of lipid metabolism could 
alter macrophage phenotype and inflammatory activity. This principle of metabolic 
immunomodulation has just started to be explored, mainly by hitting targets involved in 
glucose metabolism [83]. Still, a few studies, reviewed below, have addressed the potential of 
modulating macrophage lipid metabolism to attenuate inflammation. 
 
One study explored the contribution of FASN to the pro-inflammatory activity of M1 
murine peritoneal and Raw 264.7 macrophages [38]. M1-polarized macrophages with FASN 
knock-out displayed decreased levels in JNK phosphorylation, essential for activation of M1 
mediators, and production of pro-inflammatory cytokines, such as TNFα, IL-1β, monocyte 
chemoattractant protein 1 (MCP-1) and IL-12p40 (Figure 2A and B). Additionally, 
cholesterol levels were decreased and DRM’s lipid content from cell membrane was found to 
be altered. Furthermore, Wei and colleagues used cerulenin and C75 (4-methylene-2-octyl-5-
oxotetra- hydrofuran-3-carboxylic acid), which are drugs with FASN inhibitory action [38], to 
further explore the effects of FASN inhibition on M1 expression pattern. The results showed 
decreased M1-induced phosphorylation of JNK (Figure 2C), suggesting a possible attenuation 
of pro-inflammatory mediators. Another study explored the pro-resolving effect of FASN 
inhibition, through knocking-out FASN in murine macrophages, in the context of 
atherosclerosis [84]. The results revealed reduced atherosclerosis development, as well as 
decreased cholesterol accumulation in these macrophages. Thus, FASN inhibition in 
macrophages produced some interesting pro-resolving effects that could suggest its use as a 
therapeutic target to help regulating inflammation.  
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Makowski and colleagues explored the contribution of aP2, a membrane protein 
involved in the uptake of FA, to the pro-inflammatory activity of murine primary 
macrophages. Macrophages from aP2-/- mice reduced cholesterol and cholesterol esters 
accumulation, which was associated with an increase in cholesterol efflux proteins, typical of 
M2-like macrophages [39]. Moreover, pro-inflammatory cytokines IL-1α, IL-1β, IL-6, IL-
12p40, and TNFα levels were also reduced in these aP2-deficient macrophages (Figure 3A 
and 3B). Additionally, aP2-/- macrophages treated with LPS were deficient in MCP-1, COX-2 
and iNOS expression, commonly highly expressed in M1-like macrophages. This attenuation 
in the expression of pro-inflammatory mediators suggests aP2 as a possible pro-resolving 
target. 
Figure 3 – Impairment of aP2 attenuates M1-like pro-inflammatory phenotype. aP2-/- macrophages treated with 
LPS (M1 stimulus) display a downregulation in pro-inflammatory cytokines (A) TNF-α and (B) Il-6, and (C) 
MCP-1. M1-like typical enzymes, (D) COX-2 and (E) iNOS were also downregulated in M1 aP2-deficient 
macrophages. Adapted from Makowski et al [44]. 
Figure 2 – Results showing the impact of FASN inhibition on M1 macrophages. Raw264.7 macrophages FASN+/+ 
and FASN-/- were stimulated with LPS to acquire M1 phenotype. FASN knock-down resulted in attenuation of 
LPS-induced pro-inflammatory cytokines, TNF-α (A) and IL-1β (B) (*p<0,05). Additionally, Raw264.7 were 
treated with FASN inhibitory drugs (cerulenin and C75), and p-JNK levels were evaluated. Cerulenin and C75 
promoted decrease in p-JNK (C). Adapted from Wei et al [43].  
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Another study involved knocking-out sterol receptor element-binding protein 1a 
(SREBP1a), a transcription factor activated during M1-like polarization, which promotes 
transcription of enzymes involved in lipid metabolism [85]. Compared to the control group, 
BMDM murine macrophages deficient in SREBP1a decreased their levels of pro-
inflammatory cytokine IL-1β. This decrease was associated with reduced expression of Nlrp1a 
gene, involved in activation of caspase-1 which promotes cleavage of pro-IL-1β. Decrease in 
IL-1β, a pro-inflammatory cytokine, suggests a possible pro-resolving role for targeting 
SREBP1a and downstream associated pathways, including lipid metabolism. 
AMP-activated protein kinase (AMPK) is a crucial enzyme for cellular energy 
homeostasis, which is implicated in the regulation of mitochondrial oxidative phosphorylation, 
and lipid metabolism (through inhibition of FA synthesis and activation of FAO) [86]. 
Moreover, AMPK is capable of phosphorylating ACC and SREBP1c, inhibiting synthesis of 
FA, cholesterol and TG, and activating FA uptake and FAO. In macrophages, M1 stimulation 
decreases activation of AMPK, while M2 stimulation seems to induce AMPK activation 
[87,88], and upregulation of FAO mediators [89]. Therefore, activating AMPK might be an 
interesting approach in the context of macrophage polarization towards M2-like pro-resolving 
phenotypes. Indeed, murine M1 BMDM treated with AMPKβ1-specific activator, A769662, 
displayed a significant increase in FAO and reduced JNK activation [90]. Metformin is a well-
known drug, commonly used for the treatment of type 2 diabetes, that promotes activation of 
AMPK [91]. Recently, metformin has been explored as a pro-resolving drug in order to 
attenuate the pro-inflammatory phenotype [92,93]. Kim et al reported that metformin 
downregulated LPS-induced production of pro-inflammatory cytokines, TNF-α and IL-6 [93], 
and increased phosphorylation of acetyl-CoA carboxylase (ACC). Attenuation of these pro-
inflammatory cytokines was a result of AMPK activation, as corroborated by the similar 
results obtained through treatment with AICAR (5-aminoimidazole-4-carboxamide 
ribonucleotide), a direct AMPK activator. Additionally, treatment of M1-like macrophages 
with Compound C (CC), an AMPK inhibitor, impaired this attenuation.  
Activation of AMPK was also implicated in the anti-inflammatory action of 
palmitoleate and associated changes in lipid metabolism [94]. Palmitoleate (C16:1) was co-
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incubated with BMDM treated with palmitate, an M1-polarization stimulus. M1 BMDM 
treated with palmitoleate displayed reduced levels of Nos2, Cxcl1 and Il6 expression (Figure 
4A, 4B and 4C), reduced levels of CXCL1 and IL-6 secretion, and decreased NO production 
(Figure 4D, 4E and 4F). Some M2 typical genes were increased (Tgfb1, Il10 and Mgl2), and 
so was FAO activity. The authors suggested that the pro-resolving effect of palmitoleate 
involved activation of AMPK, as the use of CC impaired the observed changes. However, the 
mechanism through which palmitoleate activates AMPK remains unclear. 
 
 Results from these studies suggest several lipid related mediators as potential targets 
for attenuating macrophage pro-inflammatory activity. However, the implications in terms of 
promoting M2-like pro-resolving activity remain poorly studied. Future studies should include 
evaluation of M2 markers in order to explore the possible M1 to M2 transition, and not only 
Figure 4 – Palmitoleate attenuated pro-inflammatory phenotype profile of M1 macrophages. BMDM treated 
with palmitate (M1 stimulus) were co-incubated with palmitoleate. Palmitoleate treated M1 macrophages 
displayed an attenuation in (A) Nos2, (B) Il6 and (C) Cxcl1 expression. Attenuation expression was 
accompanied with (D) decreased NO production, and decreased protein levels of (E) IL-6 and (F) CXCL1. 
Adapted from Chan et al [110]. 
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M1 attenuation, as the ability to promote M2-like anti-inflammatory activity is critical for a 
balanced response and the resolution of inflammation. 
 
I.4. Immunomodulatory activity of flavonoids 
Bioflavonoids are a class of natural compounds with a polyphenolic structure, which 
are widely found in fruits, vegetables, plants and tea leaves [95], fulfilling several functions. 
For instance, some flavonoids are important flower pigments, while others are used in UV 
filtration or act as secondary messengers and physiological regulators. According to their 
structure, flavonoids can be subdivided in different groups (Figure 5): flavones and flavonols 
(which can be included in a single group called anthoxanthins), flavonones, flavanonols, 
flavans and anthocyanidins.  
Figure 5 – Representative structure of each subclass of flavonoids. A is the structure for luteolin, an example of a 
flavone. B is the structure for quercetin, an example of a flavonol. C is the structure of taxifolin, an example of a 
flavanonol. D is the structure of epigallocatechin 3-gallate (EGCG), an example of a flavan. E is the structure of 
naringenin, an example of a flavanone. F is the structure of cyanidin, an example of an anthocyanidin. G is the 
structure of naringin, an example of a glycosided flavanone. 
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These compounds display a wide range of health-promoting properties that have been 
thoroughly explored in the past decade [96]. In particular, flavonoids have been shown to have 
anti-oxidant, anti-inflammatory and anti-cancer properties, to help preventing cardiovascular 
diseases, to display anti-fungal and anti-bacterial properties, as well as favourable properties 
against different diseases, such as, diabetes, Alzheimer’s, atherosclerosis, and others. 
Flavonoids have also been studied for their immunomodulatory activity. The following 
sections will address how flavonoids modulate macrophage activation and lipid metabolism. 
 
I.4.1. Flavonoids and macrophage polarization 
The use of flavonoids to modulate macrophage polarization has been widely explored 
[97]. In terms of inflammation control, some studies have focused on downregulating pro-
inflammatory features, such as NO production, pro-inflammatory cytokines, and pathways 
related with their genetic activation. Interestingly, others have employed flavonoids to 
promote a shift from M1 macrophages to M2-like macrophages, i.e. towards a pro-resolving 
phenotype. 
The use of naringenin (Figure 5E) to modulate macrophage polarization has been 
explored in several studies. In Raw 264.7 macrophages, 25-200 µM of naringenin markedly 
promoted a decrease in LPS-induced (5 µg/mL) NO production and iNOS expression, as well 
as a decrease in TNF-α and MCP-1 [98]. In LPS-stimulated U937 macrophages, pre-
incubation with 5-50 µg/mL of naringenin reduced LPS-induced (1 µg/mL) increase in TNF-
α, IL-1β, IL-6 and IL-8 [99], as shown in Figure 6. Chao et al, observed a decrease in iNOS, 
COX-2 expression and NO production, in Raw264.7 macrophages incubated with 30-200 µM 
of naringenin and 0.1-100 µg/mL of LPS [100]. Additionally, another study observed 
inhibition of PGE2 LPS-induced production, in J774 macrophages incubated with 1-100 µM 
of naringenin [101]. In the same cell line infected with C. Trachomatis, 48h treatment with 
0.01-10 µg/mL naringenin attenuated the increase of pro-inflammatory cytokines, such as IL-
6, TNF, IL-12p70, IL-1α, IL-1β and GM-CSF, and pro-inflammatory chemokines, such as 
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CCL4, CXCL10, CXCL5, CCL5 and CXCL1 [102]. More recently, Pinho-Ribeiro et al pre-
incubated LPS-induced (1µg/mL) Raw 264.7 macrophages with 30-1000 nM of naringenin 
and observed a decrease in NF-κB activity, essential for activation of several pro-
inflammatory genes, as well as a decrease in cytokines and O2
- production [103]. 
Concordantly, Jin et al observed an inhibition in LPS-induced increase in TNF-α and IL-6 
[104], after incubation with 100 µM of naringenin.  
 
 
 
Quercetin (Figure 5B) is another abundant bioflavonoid that has been shown to 
display interesting anti-inflammatory and macrophage modulating properties [105–107]. In 
Raw 264.7 macrophages, pre-treatment with 2.5-20 μM of quercetin and post-incubation with 
Figure 6 – Naringenin attenuated pro-inflammatory cytokines from LPS-induced U937 macrophages. U937 
macrophages were pre-incubated with naringenin concentrations ranging from 5-50 µg/mL, for 2 hours, and then 
incubated with 1 µg/mL of LPS (from Aggregatibacter actinomycetemcomitans). IL-1β (A), TNF-α (B), IL-6 (C) 
and IL-8 (D) LPS-induced levels were reduced with pre-treatment with naringenin at 25 and 50 µg/mL. *p<0.05 
compared to control. Adapted from Bodet et al (108). 
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100 ng/mL of LPS promoted a decrease in iNOS and COX-2 expression, accompanied by a 
decrease in NO and PGE2 production [105]. Endale et al also observed a decrease in pro-
inflammatory cytokines, such as TNF-α, IL-1β, IL-6 and GM-CSF, as shown in Figure 7. 
Guzman and colleagues also observed a decrease in pro-inflammatory cytokines (TNF-α, IL-
1β, IL-12 and MCP-1) in BMDM pre-treated with 20 μM of quercetin and stimulated with 
10μg/mL of LPS [107]. Moreover, the pro-inflammatory activity and IL-1β production 
induced by cholesterol crystals were attenuated in quercetin treated macrophages. Another 
study involving treatment with this flavonoid reported a reduction in base levels of several 
pro-inflammatory mediators (IL-6, IL-8, IL-1β, TNF-α, IFN-γ and COX-2) [106],as well as in 
NF-κB and JNK pathways. More recently, quercetin was reported to ameliorate kidney injury, 
liver inflammation and fibrosis, through modulation of macrophage polarization [108,109]. Lu 
et al, observed that quercetin inhibited infiltration of CD68+ macrophages in renal interstitium 
[108], which was associated with a decrease in iNOS and IL-12. Moreover, quercetin-treated 
macrophages displayed a decrease in M1-like activation, found to be associated with 
decreased expression of Notch1, both in vivo and ex vivo [109]. Altogether, these results 
suggest an immunomodulatory effect for quercetin and its potential therapeutic use in 
inflammatory diseases.  
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Naringin (Figure 5G) was also explored as a natural modulator of macrophage 
polarization. In Raw 264.7 cells, naringin (50 µM – 1 mM) attenuated LPS-induced levels of 
several pro-inflammatory mediators [110,111]. This attenuation was associated with 
suppression of NF-κB activation, through inhibition of IκBα degradation and translocation of 
p65. Naringin also attenuated activation of MAPK by inhibiting phosphorylation of ERK1/2, 
JNK and p38 MAPK. More recently, Gil et al observed that incubation of in Raw264.7 
macrophages with ≤200 μM of naringin promoted a decrease in M1 markers, such as TNF-α 
and HMGB1 (Figure 8), and inhibition of AMPK [112]. 
 
Figure 7 – Quercetin attenuates TNF-α (A), IL-1β (B), IL-6 (C) and GM-CSF (D) LPS-induced levels. Pre-
incubation with 5-20 µM of quercetin markedly reduced LPS-induction of pro-inflammatory cytokines. *p<0.05, 
**p<0.01, ***p<0.001, compared to only LPS treated group. Adapted from Endale et al (114). 
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Other flavonoids have been reported to have some interesting effects on macrophage 
polarization. For instance, epigallocatechin-3-gallate (EGCG), an abundant flavonol from 
green tea with anti-inflammatory properties [113], has been shown to reduce pro-inflammatory 
mediators, such as NO and PGE2, through downregulation of iNOS and COX-2 expression, in 
LPS-stimulated macrophages [114]. The use of procyanidin dimer B2, from cocoa, which 
belongs to the flavonoid subclass of procyanidins, was shown to reduce COX-2 expression in 
THP-1 macrophages stimulated with LPS [115]. This reduction was associated with a decrease 
in the activity of pathways important for COX-2 expression and pro-inflammatory activity, 
JNK, ERK and p38 MAPK, while NF-κB was supressed. In Raw 264.7 cells, the use of 
proanthocyanidins extracts from green tea also displayed a decrease in COX-2 expression 
[116]. LPS-stimulated (40 ng/mL) macrophages were pre-incubated with the 
proanthocyanidins (0-50 μM), and revealed decreased levels of PGE2 compared to control 
groups. This decrease in COX-2 expression was also associated with a suppression of JNK, 
ERK, p38 MAPK and NF-κB pathways. Another flavonoid studied for its immunomodulatory 
activity was curcumin, a yellow pigment from the plant Curcuma longa [117]. Pre-treatment 
with curcumin (0.5-10 μM) of LPS-stimulated human PBMC and alveolar macrophages 
resulted in inhibition of several pro-inflammatory cytokines (IL-8, MIP-1α, MCP-1, IL-1β, 
and TNF-α). In Raw 264.7 macrophages, curcumin was found to inhibit of LPS-induced TNF-
α and IL-1β gene expression [118], as well as the production of the pro-inflammatory cytokine 
IL-8 [119]. 
A B 
Figure 8 – Effect of naringin on LPS-induced expression of TNF-α and HMGB1 in Raw264.7 macrophages. 
Cells were pre-treated with concentrations of naringin varying from 0 to 200 µM for 1h, and then stimulated 
with LPS (1 µg/mL) for 24h. Cells were harvested, lysed and subjected to Western Blott (A) and RT-PCR (B) to 
determine TNF-α and HMGB1 expression levels. *p<0.05. Adapted from Gil et al [112]. 
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Hence, there is already a convincing amount of evidence showing that bioflavonoids are 
able to attenuate macrophage-mediated inflammation and possibly promote pro-resolving 
phenotypes. Still, the information on the underlying biological mechanisms remains scarce.  
 
I.4.2. Flavonoids and macrophages lipid metabolism 
Assessing how flavonoids modulate macrophage lipid metabolism might provide 
relevant insights into the role of these important cell constituents on macrophage plasticity and 
effector functions. However, to our knowledge, only a few works have addressed this issue, as 
reviewed below. 
Naringin was found to inactivate ACC (likely downregulating FA synthesis) in Raw 
264.7 macrophages via activation of AMPK signaling [112]. AMPK was also implicated in 
the action of naringenin towards THP-1 derived macrophages, where it caused increased 
expression of the Liver X Receptor LXR-α (a key regulator of transcriptional programs 
involved in lipid homeostasis and inflammation), and of proteins controlling cholesterol efflux 
(ABCA1 and ABCG1) [120]. Reverse cholesterol transport was increased and cell migration 
was inhibited, leading the authors to suggest that this polyphenol could be useful in preventing 
atherosclerosis and foam cell progression. The proteins LXR-α, ABCA1 and/or ABCG1 were 
also found to be modulated by quercetin [121], cyanidin [122] and chrysin [123], promoting 
increased cholesterol efflux in both human and murine macrophages. Additionally, in M1-like 
macrophages, quercetin was reported to inhibit ACC and to up-regulate CPT1a, a crucial 
mediator of FAO, while decreasing several pro-inflammatory mediators (Figure 9) [124]. 
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The few works described above attest the implication of lipid-related pathways in the 
attenuation of macrophage inflammatory activity, promoted by flavonoids. However, there is 
still very little knowledge on how macrophage lipids change upon flavonoid treatment or 
about the role of different lipid species in macrophage responses to these natural compounds. 
The lipidomics approach employed in this thesis, and briefly presented in the following 
section, constitutes a powerful tool to address this problem. 
 
 
 
 
Figure 9 - Modulation of M1-like phenotype profile by quercetin. Murine BMDM were pre-treated with 
quercetin, followed by treatment with LPS, compound C (CC) and/or AICAR, an inhibitor and an inducer of 
AMPK, respectively. Quercetin pretreatment resulted in attenuation of M1-like genes, such as (A) Nos2, and 
pro-inflammatory cytokines (B) Il-6 and (C) Il-1β. Additionally, (D) ACC was inhibited, as depicted by 
increased ACC phosphorylation. Pre-treatment with quercetin also promoted expression of M2-like typical 
genes, (E) Cpt1a and (F) Il-10. *p<0.05, **p<0.01, ***p<0.001. Adapted from Dong et al [108]. 
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I.5. Macrophage lipidomics 
I.5.1. The Lipidomics approach 
The whole set of lipid species comprised within a cell, tissue or organism is known as 
the lipidome, and is considered to be a subset of the metabolome [125]. Lipidomics addresses 
the large-scale characterization of the lipidome, aiming at simultaneously detecting and/or 
quantifying a large number of different lipid molecules, as well as their variations in response 
to exogenous stimuli, diseases or any biological/biomedical condition under study.  
The central analytical platform in lipidomics is mass spectrometry (MS), which can be 
employed based on direct infusion (shotgun lipidomics) or after chromatographic separation of 
lipids, e.g. through liquid chromatography (LC) [126]. The general workflow for LC-MS 
lipidomics, performed in this work, is show in Figure 10. The first step involves extracting 
lipids from the biological matrix, typically through Folch or Bligh Dyer methods [127,128], 
which use chloroform and methanol as extracting solvents. After extraction, the lipid mixture 
is injected into an HPLC column to perform separation of lipid species before MS-based 
detection. To be detected, molecular lipid ions must be generated, using an ionization method, 
such as electrospray ionization (ESI), matrix assisted laser desorption ionization (MALDI) or 
desorption electrospray ionization (DESI). As a soft ionization technique with minimal ion-
source fragmentation, ESI is predominantly employed in lipidomics. Full MS and/or MS/MS 
data (to provide fragment ion information) are then acquired, so that the resulting data consist 
of ion chromatograms and MS spectra. Finally, data analysis typically entails peak 
identification and integration, together with multivariate analysis to identify consistent 
variation patterns and the varying lipid species. 
 
Figure 10 - Workflow of lipidomics. Lipids from biological samples are extracted in organic solvents. 
Extracted lipids are then separated through chromatography or they are directly infused (shotgun lipidomics) in 
the mass spectrometer. Peak identification and integration allows characterizing changes in lipids.  
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I.5.2. Lipidomics studies of macrophages 
The utility of MS-based lipidomics for unravelling the lipidome of macrophages has 
been demonstrated by several recent works. Table 2 provides a compilation of some 
representative studies addressing the lipidomic changes of murine or human macrophages in 
response to different stimuli.  
In an early work, Dennis and coauthors have described the lipidomic response of 
murine RAW 264.7 cells to Kdo2-lipid A (KLA), an active component of LPS [73]. Several 
changes were identified in the cells fatty acids profile, which, together with transcriptomics 
data, suggested increased eicosanoid synthesis. Remodelling of glycerolipids, 
glycerophospholipids, and prenols was also observed, reflecting alterations in most lipid 
classes during the inflammatory response. The impact of KLA on the RAW macrophage 
lipidome has also been studied at the subcellular level [129]. It was found that while some 
changes were common to all organelles (e.g., increases in the levels of ceramides and 
cholesterol precursors), others were organelle-specific.  For example, oxidized sterols 
increased and unsaturated cardiolipins decreased in mitochondria, whereas unsaturated ether-
linked phosphatidylethanolamines decreased in the endoplasmic reticulum. KLA-primed 
mouse bone marrow-derived macrophages were also examined for lipidomic changes upon 
exposure to ATP (interpreted as ‘a danger signal’) [67]. The results suggested that STATs 
were synergistically activated, with STAT1 and STAT3 regulating triacylglycerols and 
eicosanoids metabolism, respectively. In a more recent study, LC-MS based lipidomics was 
used to profile different lipid classes in Raw 264.7 macrophages treated with various LPS 
concentrations [130]. Triglycerides, diacylglycerol, cholesterol, phosphatidylethanolamine 
(PE), phosphatidylserine (PS), phosphatidylinositol (PI), phosphatidic acid (PA), lyso-
phosphatidylcholine (LPC), lyso-phosphatidylethanolamine (LPE), ceramides (Cer), and 
dihydroceramides (dCer) were increased, whereas cholesterol, PC and lysophosphatidic acid 
(LPA) were decreased in a concentration-dependent manner. Moreover, treatment of activated 
macrophages with an anti-inflammatory compound, rosiglitazone, recovered the levels of 
several lipid species.  
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Table 2 - MS-based lipidomics studies of macrophages exposed to different stimuli. 
 
Cells Stimuli 
Analytical 
technique 
Main lipidomic findings Reference 
M1/M2 canonical stimuli 
Primary 
human 
macrophages 
IFN-γ+LPS (M1) 
IL-4 (M2a) 
IL-10 (M2c) 
SFC-IM-MS 
Different levels of AA mobilization; 
Thromboxane A2 production; Changes 
in FA profile. 
[131] 
Raw 264.7, 
THP-1 
macrophages 
LPS (M1) 
IL-4+IL-13 (M2) 
HPLC-ESI-MS 
Higher levels of lysophospholipids in 
M2. 
 
[132] 
Incubation with Lipids 
Primary 
human 
macrophages 
eLDL, oxLDL ESI-MS/MS 
Saturation dependent changes in PC and 
PE plasmalogens; downregulation of 
endogenous synthesis of cholesterol and 
its exogenous uptake. 
[133] 
Mouse 
BMDM 
Laurate, myristate, 
palmitate, stearate, 
oleate 
LC-ESI-
MS/MS 
Altered PL saturation status. [134] 
Mouse 
BMDM 
Palmitic acid, 
gamma-T3 
LC-MS/MS 
Gamma-T3 treatment caused: decreases 
in lysophospholipids, diacylglycerol 
and free AA; decreased PGE2 secretion; 
attenuated ceramide synthesis; rescued 
ATP production. 
[135] 
Other Stimuli 
Raw 264.7 
Aspirin+KLA, 
Ibuprofen+KLA 
UPLC-Q-TOF-
MS 
PC(17:1/18:1) and PA(18:0/18:4) 
identified as inflammatory response 
targets to aspirin and ibuprofen; Aspirin 
and ibuprofen inhibited COX, induced 
FA desaturation and changes of PL 
components. 
[138] 
J774A.1 Bisphenol S  LC-MS/MS 
BPS modulated, glycerophospholipids 
and acylglycerols. 
[137] 
Raw 264.7, 
BMDM 
TiO2 nanoparticles GC-MS 
Decreased levels of cardiolipins; 
Increased PGD2, PGE2, 15d-PGJ2,  
COX-2 metabolites. 
[136] 
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The lipidomic profile of M1- and M2-polarized human macrophages has been 
investigated in two recent studies. Montenegro-Burke and colleagues obtained primary human 
macrophages differentiated from blood monocytes and activated them with IFN (M1), IL-4 
(M2a) and IL-10 (M2c) [131]. By employing supercritical fluid chromatography-ion mobility 
mass spectrometry analysis, alterations in several classes of membrane phospholipids and fatty 
acids were found in differentially polarized cells. Moreover, some biologically relevant 
eicosanoids were quantified in cells culture media. The results showed different levels of 
arachidonic acid mobilization as well as other fatty acid changes, reflecting activation of 
processes related to the cell membrane remodelling and the biosynthesis of lipid signalling 
molecules. In the other study, Zhang et al. detected 300 lipid molecules in human and murine 
macrophages and identified changes during their polarization with LPS (M1) and with IL-
4/IL-13 (M2) [132].  In general, macrophage activation was accompanied by a striking shift in 
the composition of glycerophospholipids (GLs) from saturated and monounsaturated to 
polyunsaturated. Moreover, M2 macrophages showed higher levels of lysophospholipids 
(lysoGLs) than M1 macrophages. Differences in specific lipid species noted in macrophages 
differentiated from monocytic THP-1 cells (also used in this thesis), at different polarization 
states, are summarized in Table 3.   
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Table 3 - Variations in GLs of THP-1 macrophages activated with LPS (M1) or with IL-4 and IL-13 (M2), 
compared to unstimulated macrophages (M0). 
 
Class Phenotype Glycerophospholipids Variation 
PC 
M1 
PC(34:5), PC(36:4), PC(36:5), PC(38:1), PC(38:2), PC(38:4), PC(38:5), 
PC(38:6), PC(38:7), PC(40:4), PC(40:5), PC(40:6), PC(40:7), PC(40:8) 
↑ 
M2 
PC(34:5), PC(36:5), PC(38:1), PC(38:2), PC(38:4), PC(38:7), PC(40:5), 
PC(40:6); PC(40:7), PC(40:8) 
↑ 
PI 
M1 
PI(32:2), PI(34:4), PI(36:4), PI(36:5), PI(36:6), PI(38:4), PI(38:5), PI(38:6), 
PI(40:7) 
↑ 
PI(30:0), PI(30:2), PI(34:0), PI(34:1), PI(36:0), PI(36:1), PI(36:2), PI(38:1), 
PI(38:2), PI(40:5) 
↓ 
M2 
PI(32:2), PI(34:4), PI(36:4), PI(36:5), PI(38:4), PI(38:5), PI(38:6), PI(40:7) ↑ 
PI(30:0), PI(32:1), PI(34:1), PI(36:0), PI(36:1), PI(36:2), PI(38:1), PI(38:2), 
PI(40:5) 
↓ 
PS 
M1 
PS(36:3), PS(36:5), PS(38:3), PS(38:4), PS(38:5), PS(38:6), PS(40:4), 
PS(40:5), PS(40:6) 
↑ 
PS(32:1), PS(32:2), PS(34:1), PS(34:2), PS(38:1) ↓ 
M2 
PS(36:3), PS(36:5), PS(38:3), PS(38:5), PS(38:6), PS(40:5), PS(40:6) ↑ 
PS(32:1), PS(34:1), PS(38:1) ↓ 
LPC 
M1 LPC(20:3), LPC(20:4), LPC(20:5), LPC(22:4), LPC(22:6) ↑ 
M2 LPC(20:4), LPC(20:5), LPC(22:4) ↑ 
LPE 
M1 LPE(20:1), LPE(20:4), LPE(20:5), LPE(22:6) ↑ 
M2 
LPE(20:1), LPE(20:4), LPE(20:5), LPE(22:6) ↑ 
LPI(18:0), LPI(18:2), LPI(20:4) ↓ 
LPG M1 LPG(14:0), LPG(16:1), LPG(18:1) ↓ 
LyPS 
M1 
LyPS(18:2), LyPS(20:3), LyPS(20:4), LyPS(20:5), LyPS(22:4), LyPS(22:5) ↑ 
LyPS(16:0), LyPS(16:1), LyPS(18:0), LyPS(22:0) ↓ 
M2 LyPS(16:0), LyPS(16:1), LyPS(18:0), LyPS(22:0) ↓ 
 Legend: PC – phosphatidylcholine; PE – phosphatidylethanolamine; PI – phosphatidylinositol; PS – phosphatidylserine; LPC – 
lysophosphatidylcholine; LPE – lysophosphatidylethanolamine; LPG – lysophosphatidylglycerol; LyPS – lysophosphatidylserine; ↑ - 
increase; ↓ - decrease. 
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A few studies have addressed lipidomic changes upon macrophage loading with lipids, 
which represents a pro-inflammatory stimulus particularly relevant in the context of 
atherosclerosis, obesity and other metabolic diseases. Exposure of primary human 
macrophages to enzymatically modified and oxidatively modified lipoproteins (eLDL and 
oxLDL, respectively) led to a transient, strong elevation of LysoPC [133]. Analysis of 
individual lipid species showed LDL-dependent effects for LysoPC, choline plasmalogens 
(PC-P) and ethanolamine plasmalogens (PE-P) species. On the other hand, changes related to 
downregulation of endogenous lipid synthesis were common to all stimuli. In another work, 
primary murine macrophages were treated with saturated and unsaturated fatty acids (FA) 
[134]. All FA produced strong changes in numerous lipid species within all classes assessed, 
being especially pronounced for phosphatodylcholine and ether-phosphatidylcholine lipid 
species. Kim et al. have also stimulated LPS-primed bone marrow derived macrophages with 
saturated FA along with gamma-tocotrienol (gamma-T3), an unsaturated vitamin E that has 
been shown to attenuate the NLRP3 inflammasome [135]. The SFA-mediated inflammasome 
activation induced robust changes in species of glycerolipids, glycerophospholipids, and 
sphingolipids in BMDM, while the gamma-T3 treatment caused substantial decreases of 
lysophospholipids, diacylglycerol, and free arachidonic acid (AA, C20:4), indicating its 
limited availability for the synthesis of eicosanoids. In addition, gamma-T3 attenuated 
ceramide synthesis by transcriptional downregulation of key de novo synthesis enzymes. 
Additionally, the MS-based lipidomics approach has also been employed to assess 
macrophage responses to titanium nanoparticles [136], the chemical Bisphenol S [137] and 
anti-inflammatory drugs [138], as summarized in Table 3.  
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The studies mentioned above demonstrate that MS-based lipidomics is an exquisitely 
valuable approach to characterize changes in macrophage lipid composition and metabolism in 
response to various stimuli. However, to the best of our knowledge, the effects of flavonoids 
on macrophage lipidome haven’t been previously studied. In this work, LC-MS lipidomics is 
employed for the first time to evaluate how three flavonoids (Quercetin, Naringin and 
Naringenin), with reported anti-inflammatory activity, modulate different lipid classes in 
human macrophages. 
 
I.6. Objectives of this work 
This work aims at characterizing the changes in the phospholipidome of human 
macrophages in response to three flavonoids with well-known anti-inflammatory activity: 
quercetin, naringin and naringenin. In particular, specific objectives are: 
- To reveal the main variations in PL species upon flavonoid treatment of resting (M0) 
and M1 pre-polarized macrophages; 
- To identify PL variations in flavonoid-treated macrophages that may potentially be 
related to their anti-inflammatory activity; 
- To compare the effects induced by the three flavonoids; 
- To highlight features that may advance current understanding of flavonoids mode of 
action, particularly regarding the remodeling of cellular lipids. 
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II. Materials and methods 
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II.1. Differentiation and polarization of THP-1 cells 
Human monocytic THP-1 cells (ATCC, Virginia, USA) were cultured in Roswell Park 
Memorial Institute medium (RPMI 1640, Gibco, #51800-035) culture medium containing 10% 
of heat-inactivated fetal bovine serum (FBS), 1% of penicillin/streptomycin and supplemented 
with 2.0 g/l sodium bicarbonate (Sigma Aldrich, #55761-500G). Cells were maintained in 
culture at 37ºC and 5% of CO2.  
THP-1 monocytes were differentiated into macrophages (M0) by 24-hour incubation 
with 50 ng/mL of phorbol 12-myristate 13-acetate (PMA, Sigma Aldrich, #P8139-1MG) in 
RPMI medium, which was followed by a 24h rest in new medium. M1 macrophage 
polarization was carried out by 24-hour incubation with 20 ng/mL of interferon-γ (IFN-γ, 
Biolegend, #570206) and 100 ng/mL of lipopolysaccharides (LPS, Sigma Aldrich, L4391-
1MG). To obtain M2 macrophages, M0 cells were incubated with 20 ng/mL of interleukin-4 
(IL-4, Biolegend, #574004) and 20 ng/mL of interleukin-13 (IL-13, Biolegend, #571104), for 
48h. All experiments were performed with cells at passage 10 to 17. 
 
II.2. Fluorescence microscopy 
THP-1 monocytes were seeded at 30.000 cells/well in µ-slide 8 well adherent plates 
(ibidi, Germany), differentiated into macrophages, and subsequently polarized to M1 and M2, 
as described above. 
After medium removal and phosphate-buffered saline solution (PBS) washing, cells 
were fixated with Formaline 4%, washed once with PBS, blocked with a 5% BSA solution for 
30 mins and washed again for three times with PBS. Fixated macrophages were incubated 
with respective antibody panels for the M1 phenotype (Alexa Fluor 488 anti-human CD 80 
[Biolegend, clone #305214 2D10] and PyE [phycoerythricin] anti-human CD64 [Biolegend, 
#305008 clone 10.1]) and the M2 phenotype (FITC anti-human CD36 [Biolegend, #336206 
clone 5-771] and PyE anti-human CD209 [Biolegend, #330104 clone 9E9A8]) for a 1-hour 
period. This was followed by a 15-min incubation with a 2:1000 solution of DAPI (4′,6-
diamidino-2-phenylindole). Cells were washed 5 times with PBS and stored in PBS at 4ºC 
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until observation. Mounting medium was added to each well and observation proceeded in a 
fluorescence microscope (ZEISS AxioImager M2, equipped with a 10x/0.25 objective – Carl 
Zeiss, Germany). 
 
II.3. Cell Viability Assay 
To assess the toxicity of flavonoids in THP-1-derived macrophages and select the 
concentrations to be used in subsequent experiments, the Alamar Blue reduction assay was 
performed. THP-1 monocytes were seeded at 30.000 cells/well in 96-well, differentiated, and 
treated with quercetin (Alfa Aesar, #A15807), naringin (Sigma Aldrich, #71162-25G), or 
naringenin (Sigma Aldrich, #BCBT8724) at concentrations ranging from 0 to 200 µM, during 
24h incubation period. The medium was then discarded and cells were incubated with a 10% 
solution of alamar BlueTM Cell Viability Reagent (Invitrogen, #DAL1025, alamar 
Blue/RPMI 1640 medium) for 24 h. Each well’s solution was then transferred into a black flat 
bottom 96-well plate, and fluorescence was measured at 540/600 with BioTek Synergy HTX 
Multi-mode Reader, using Gen5 Microplate Reader and Imager Software Version 2.09 
(BioTek Software, Wisconsin, VT, USA). 
Statistical analysis was performed using GraphPad Prism version 6.01 (GraphPad 
Software, San Diego, CA). All data were analysed by one-way ANOVA, with a Newman-
Keuls multiple comparison test, to evaluate statistical significance of intergroup differences in 
all the tested variables. p-values <0.05 were considered statistically significant. 
 
II.4.  Quantification of cytokines (LEGENDplex assay) 
To assess the production of pro- and anti-inflammatory cytokines by macrophages 
exposed to M1 and M2 canonical stimuli, as well as to the three flavonoids, cell medium 
supernatants were analysed by bead-based LEGENDplex assay (#740509, Human M1/M2 
Macrophage Panel 10-plex with V-bottom plate, BioLegend, London). The M1 panel was 
composed of IL-12p70, TNF-α, IL-6, IL-1β, IL-12p40, IL-23 and CXCL10, whilst the M2 
panel was composed of IL-6, IL-10, CCL17 and IL-1RA. Standards were initially prepared 
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from a cocktail of cytokines. Standards and samples were added to a V-bottom plate, together, 
with 25 μL of Assay Buffer (AB). A solution of fluorescence-encoding beads was then added 
to both standards and samples. The plate was sealed, covered from light, and placed in a plate 
shaker at 750 rpm for 2h, at room temperature. After shaking, the plate was centrifuged for 5 
min at 250xg, the supernatant discarded, the plate was washed with 1X Wash Buffer (WB) 
and submitted to a second centrifugation for 5 min at 250xg. Then after discarding the 
supernatant, detection antibodies were added to each well. The plate was sealed and shook for 
1 hour at 750 rpm, at room temperature, after which, 25 μL of streptavidin-phycoerythrin (SA-
PyE) were added to each well. The plate was again sealed and shook for 30 min at 750 rpm, 
supernatant discarded and a final centrifugation/washing step was performed. Finally, beads 
were ressuspended in 150 μL of WB. 
Standards and samples were read on a flow cytometer BD Accuri™ C6 (BD 
Biosciences). The minimum detection limits of the LEGENDplex assay for the analysed 
cytokines were: IL-12p70 (1.0 pg/mL), TNF-α (1.4 pg/mL), IL-6 (1.1 pg/mL), IL-1β (1.3 
pg/mL), IL-12p40 (9.9 pg/mL), IL-23 (1.7 pg/mL), CXCL10 (1.4 pg/mL), IL-10 (1.0 pg/mL), 
CCL17 (2.1 pg/mL), IL-1RA (48.7 pg/mL). The maximum measurable was 10 ng/mL for all 
cytokines.  
To analyse cytokine measurements, the LEGENDplex v8.0 software was used. 
Statistical analysis was performed using GraphPad Prism version 6.01 (GraphPad Software, 
San Diego, CA). 
 
II.5. Sample preparation for lipidomics  
II.5.1. Flavonoid treatments  
THP-1 monocytes at cell passage 15-17 were seeded at 1x106 cells/mL in cell culture 
dishes and differentiated as described in II.1. After 24-hour in fresh medium, macrophages 
were treated with 60 µM of quercetin (Alfa Aesar, #A15807), 200 µM of naringin (Sigma 
Aldrich, #71162-25G), or 100 µM of naringenin (Sigma Aldrich, #BCBT8724), for a period of 
48h. Pre-polarized M1 macrophages were also subjected to 24h flavonoid exposure (at the 
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same concentrations). Appropriate controls were used in all cases. Figure 11 provides a 
schematic representation of the samples collected for subsequent extraction. 
 
II.5.2. Cell extraction 
Lipids were extracted from macrophages according to the extraction protocol 
established by Bligh and Dyer [128]. This method partitions lipids into an organic phase by 
using a 1:2 chloroform:methanol ratio.  
Firstly, the medium was removed and the cells were washed four times with PBS. 
Then, 1 mL methanol 80% (v/v) (Sigma Aldrich, HPLC grade) was added to the dish to 
quench metabolic activity and cells were scrapped off. The cell suspension was transferred 
into a glass tube containing 0.5 mm glass beads (to aid cell suspension), which was kept on ice 
until cell samples were quenched.  
After 2 min vortexing, 400 µL of cold chloroform (VWR, HPLC grade) were added to 
each tube followed by vortexing and another addition of 400 µL of chloroform and 360 µL 
cold milli-Q water. Samples were vortexed again and left to rest on ice for 20 min. 
Figure 11 – Schematic representation of cell culture and incubation with flavonoids and other compounds. 
THP-1 monocytes were differentiated into macrophages using 50 ng/mL of PMA for a 24-hour period, followed 
by a 24-hour resting period in new medium. Macrophages were then stimulated with either 60 µM of quercetin, 
200 µM of naringin, 100 µM of naringenin, 100 ng/mL of LPS and 20 ng/mL of IFN-γ, or 20 ng/mL of IL-4 
and 20 ng/mL of IL-13. Additionally, some dishes with cells treated with 100 ng/mL of LPS and 20 ng/mL of 
IFN-γ were also treated with 60 µM of quercetin, 200 µM of naringin and 100 µM of naringenin. 
PMA 
+ 24h 
PMA-free 
medium 
THP-1 Macrophages 
Il-4+Il-13 
Que, Nar 
or Ngn 
LPS+IFN-γ Que, Nar 
or Ngn 
48h 
48h 
24h 24h 
EXTRACTION 
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Then, after centrifugation at 3000xg for 10 min (Centrifuge 5702, Eppendorf), two 
phases were separated. The bottom organic phase was transferred into an amber glass vial and 
the remaining sample was re-extracted with 400 µL of chloroform, to collect the organic phase 
again and add it to the previous vial. 
Removed medium was collected and centrifuged at 1000xg for 10 min. The 
supernatants were then collected and stored at -80ºC. Aqueous phases were also processed and 
stored for NMR metabolomics, performed in the scope of another thesis.  
II.5.3. Phospholipid quantification 
In order to determine the phospholipid (PL) amount in each lipid extract, the 
phosphorous assay was performed according to Bartlett and Lewis [140]. Phosphate standards 
from 0.1 to 2 μg of phosphorous (P) were prepared from a monosodium phosphate solution 
(100 µg/mL, NaH2PO4.2H2O). 
 Dried aliquots of samples and standards were re-suspended in 125µ of perchloric acid. 
Samples were then heated at 180ºC in a heating block (Stuart, U.K.), for 40-60 min, followed 
by cooling at room temperature. Thereafter, 825 μL of milli-Q water  125  μL of 2.5% solution 
of ammonium molybdate (2.5g ammonium molybdate/100 mL milli-Q water) and 125 μL of 
10% ascorbic acid (10g ascorbic acid/100 mL milli-Q water) were added to samples and 
standards, vortexed after each addition and incubated for 10 min at 100ºC in a water bath. 
After cooling in a cold water bath, the samples and standards absorbance was measured at 797 
nm in a microplate reader (Multiscan 90, ThermoScientific). Four independent measurements 
were performed for each sample type (i.e. exposure condition). 
II.5.4. Sample preparation for LC-MS 
Dried samples were resuspended in dichloromethane to have a PL concentration of 1 
µg/µL (each volume was determined based on phospholipid quantification). From each 
sample, 5 µL (representing 5 µg of phospholipid) were taken and transferred to an appropriate 
vial, followed by addition of 91 µL of a solvent system consisting of two mobile phases in a 
proportion of 60% eluent B (60% acetronitrile, 40% methanol, and 1 mM of amonium 
acetate), and 40% eluent A (50% of acetonitrile, 25% of methanol, 25% of water, and 1 mM 
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of amonium acetate, and 4 µL of an internal standards mixture containing PC(14:0/14:0), 
PE(14:0/14:0), PG(14:0/14:0), PI(14:0/14:0), PS(14:0/14:0), PA(14:0/14:0), LPC(19:0), 
Cer(18:1/15:0), SM(d18:1/17:0), and CL(14:0/14:0/14:0/14:0).  
 
II.6. Mass Spectrometry 
II.6.1. Data acquisition 
Phospholipids were separated through hydrophilic interaction liquid chromatography 
(HILC-LC) using an Ascentis Si HPLC Pore (15 cm x 1.0 mm, 3 µm; Sigma-Aldrich) and a 
high performance-liquid chromatography (HPLC) system (Ultimate 3000 Dionex, Thermo 
Fisher Scientific, Bremen, Germany) with an autosampler coupled online to the Q-Extractive® 
hybrid quadrupole Orbitrap® mass spectrometer (Thermo Fisher Scientific, Bremen, 
Germany). An aliquot of 5 µL of each sample mixture was injected into the HPLC column, at 
a flow rate of 40 µL/min and a temperature of 30ºC. Initially, 40 % of mobile phase A was 
held isocraticallty at 8 min, followed by a linear increase to 60% of mobile phase A for 7 min, 
a 5-min maintenance period and the return to initial conditions within 5 min. A 10-min 
interval was given between injections to allow return to equilibrium. The mass spectrometer 
with a Q-Extractive® orbitrap and a heated electrospray ionization (HESI) operated 
simultaneously in positive mode (voltage of 3 kV) and negative mode (voltage of -2.7 kV). 
The sheath gas flow rate was maintained at 15 units and the capillary temperature was 250ºC, 
while S-lenses RF was of 50 units and probe’s temperature was 100ºC. Mass spectral 
acquisition method was at full scan in a scale of m/z values of 200-1600, with a resolution of 
70.000, automatic gain control of 1x106 and 2 microscans. The 10 most abundant ions were 
selected for ion fragmentation at collision cell HCD. Collision energy varied between 25, 30 
and 35 eV. The tandem mass spectra (MS/MS spectra) were obtained at a resolution of 17.500, 
automatic gain control of 1x105, 1 microscan, and an isolating window of 1 m/z. Ion selection 
was limited to 2x104 countings. Maximum accumulated ions were established at 100 ms for 
MS spectra and 50 ms for MS/MS spectra. Dynamic exclusion was defined as 60 s. 
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II.6.2. Peak assignment and integration 
To identify phospholipid classes in each experimental condition, the acquired spectra 
were analysed using the data acquisition software Xcalibur v3.3 (Thermo Fisher Scientific, 
USA). Identification was performed based on 5 ppm of the lipid exact mass measurements and 
MS/MS spectra interpretation. After identification, quantification of molecular species was 
performed through integration of chromatographic peaks. Mass spectra were processed and 
integrated using the software MZmine v2.32. The software allows for filtering and smoothing, 
peak detection, peak processing, and assignment against in-house database [141]. During the 
processing of raw data acquired in full MS mode, all the peaks with raw intensity lower than 
1x105 were excluded.  
Relative quantification was performed by exporting peak areas values into a computer 
spreadsheet (Excel, Microsoft, Redmond, WA). For normalizing the data, peak areas of the 
extracted-ion chromatograms (XIC) of each lipid molecular species were divided by the sum 
of total XIC areas of the identified PL species. 
 
II.6.3. Multivariate and univariate statistics 
Multivariate analysis of data matrices (normalized peak areas of lipid species in the 
different samples) was performed using Metaboanalyst [142]. The data was log-transformed 
and scaled to unit variance (auto-scaling) before Principal Component Analysis (PCA) and 
Partial-least Squares Discriminant Analysis (PLS-DA). The results were visualized in scores 
scatter plots and VIP plots showing the top variables contributing for sample discrimination. 
Univariate data analysis was performed using Excel (Microsoft, Redmond, WA), to produce 
Volcano Plots, and R software (R i386 version 3.2.3), to obtain Boxplots and Heatmaps. For 
assessing statistical significance using multiple comparisons, ANOVA with Sidak correction 
was performed on GraphPad Prism version 6.01 (GraphPad Software, San Diego, CA). 
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III. Results and Discussion 
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III.1. Characterization of M1 and M2 macrophages 
III.1.1. Phenotypic markers 
To confirm that M1 and M2 macrophages were obtained through the canonical stimuli 
employed (LPS/IFN-γ and IL-4/IL-13, respectively), the expression levels of surface receptors 
typically increased in each phenotype were evaluated through immunostaining and 
fluorescence microscopy. The surface proteins CD64 and CD80 were used as M1 markers, 
while CD209 and CD36 were used as M2 markers [143]. Figure 12A displays the expression 
of CD64 in LPS/IFN-γ stimulated macrophages, stained in orange. Expression of CD80 was 
not detected. Figure 12B represents the expression of CD209 (stained in green) and CD36 
(stained in orange) in IL-4/IL-13-stimulated macrophages. Both receptors were markedly 
detected. 
 
To further assess macrophage phenotypic features, we measured the levels of different 
cytokines in the cells medium supernatant. LPS/IFN-γ produced an up-regulation of some pro-
inflammatory cytokines (Figure 13A). In particular, TNF-α, IL-6, IL-1β and CXCL10 were 
significantly increased compared to control M0 macrophages (p<0.0001). On the other hand, 
when macrophages were activated with 20 ng/mL of IL-4 and 20 ng/mL of IL-13, we 
observed an up-regulation of the levels of CCL17 and IL-1RA, two anti-inflammatory 
cytokines (Figure 13B). CCL17 is a small cytokine belonging to the chemokine class that 
Figure 12 – Expression of surface receptors in THP-1 macrophages activated to M1 (LPS+IFN-γ, 24h) and 
M2 (IL-4+IL-13, 48h) phenotypes. (A) M1 activated macrophages expressing CD64. (B) M2 activated 
macrophages expressing CD209 and CD36. CD64 and CD36 are stained in orange, while CD209 is stained 
in green. Cell nuclei are stained in blue. 
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attracts dendritic cells and monocytes. CCL17 has been previously found up-regulated in M2-
like macrophages [27]. IL-1RA is a natural inhibitor of the pro-inflammatory effect of IL-1β 
and has also been identified to characterize M2-like phenotype [144]. Curiously, the levels of 
another well-known anti-inflammatory cytokine (IL-10) did not increase significantly in IL-
4/IL-13 polarized macrophages. 
 
Still, based on the data described above, comprising surface markers and cytokine 
production, we may conclude that the polarization stimuli employed generated pro-
inflammatory and anti-inflammatory macrophages. For the sake of simplicity, these 
macrophages will be designated as M1 and M2 cells along this thesis.  
  
B A 
Figure 13 – Changes in the expression of pro- and anti-inflammatory cytokines of M1-like and M2-like polarized 
macrophages. IL-12p70, TNFαa, IL-6, IL-1β, IL-12p40, IL-23 and CXCL10 are pro-inflammatory cytokines. IL-10, 
CCL17 and IL-1RA are anti-inflammatory cytokines. **, **** statistical significance (p<0.01, p<0.0001, 
respectively). Error bars represented as mean±SD. (n=3) 
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III.1.2. Lipid composition 
III.1.2.1. Description of macrophage phospholipidome 
Interpretation of mass spectrometry data collected for macrophage lipid extracts 
allowed identification and quantification of phospholipid (PL) species. Each PL class typically 
displays a characteristic retention time (RT) range. The chromatogram in Figure 14 shows a 
time-dependent representation of the relative abundance of PL species from a sample, often 
referred to as total ion chromatogram (TIC), in negative ion mode. The reconstructed-ion 
chromatogram (RIC) is a mass-dependent representation of the relative abundance of PL 
species. Figures 15-21 A display a representative MS spectrum of each class identified. 
Identification of individual PL species was achievable through MS and MS/MS data 
interpretation. We identified 147 PL species belonging to 8 different classes: 
phosphatidylcholines (PC; with both diacyl and alkyl-acyl species), 
phosphatidylethanolamines (PE; with both diacyl and alkyl-acyl species), lyso-
phosphatidylcholines (LPC), lyso- phosphatidylethanolamines (LPE), phosphatidylglycerols 
(PG), phosphatidylinositols (PI), phosphatidylserines (PS), and sphingomyelins (SM).  These 
PL species can be found on Table 5.  
Figure 14 - Representative TIC from THP-1 macrophages. 
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Identification of each PL species was based on the retention time of its class and exact 
mass of the species, together with characteristic fragment ions or neutral losses for each class 
found in MS/MS spectra, in both negative and positive ion mode. Additionally, fatty acyl-
chains were identified through interpretation of MS/MS spectra of each species, in negative 
ion mode, by the identification of carboxylate anions, RCOO- ions. The identification of the 
most abundant species from each class is explained in detail along the following paragraphs. 
Phosphatidylcholines (PC) were identified in positive ion mode, as [M+H]+ ions. The 
most abundant PC molecular species was identified at m/z 760.5848 [PC(34:1)]. The MS/MS 
spectrum showed the abundant ion at m/z 184.0730, which corresponds to the phosphocholine 
polar head group. PC were also identified in negative ion mode, as [M+CH3COO]- ions, 
which corresponds to a mass shift of plus 58.0055 Da in comparison with the [M+H]+ ions. 
The most abundant PC molecular species was found at m/z 818.5908 [PC(34:1)]. The MS/MS 
spectrum showed product ions at m/z 168.0421, corresponding to the demethylated 
phosphocholine polar head group. The presence of these two types of product ions in both 
positive and negative ion mode MS/MS allowed to confirm the presence of PC molecular 
species. It was also possible to observe the carboxylate anions of fatty acyl chains 16:0 
(R1COO
-) at m/z 255.2324 and 18:1 (R2COO
-) at m/z 281.2482. Therefore, this PC species 
could be identified as PC(34:1) [PC(16:0/18:1)]. 
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Phosphatidylethanolamines (PE) were identified in positive ion mode, as [M+H]+ ions. 
The most abundant PE molecular species were identified at m/z 768.5531 [PE(38:4)]. The 
MS/MS spectrum showed product ions at m/z 627.5308, formed due to neutral loss of 
141.0191, which corresponds to the phosphoethanolamine polar head group. PE were also 
identified in negative ion mode, as [M-H]- ions. The most abundant PE molecular species was 
found at m/z 766.5367 [PE(38:4)]. The MS/MS spectrum showed the abundant ion at m/z 
140.0108 corresponding to the phosphoethanolamine polar head group. The presence of these 
two types of product ions allowed to confirm the presence of PE molecular species. It was also 
possible to observe the carboxylate anions of fatty acyl chains 18:0 (R1COO
-) at m/z 283.2644 
and 20:4 (R2COO
-) at m/z 303.2330. Therefore, this PE species could be defined as PE(38:4) 
[PE(18:0/20:4)]. 
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Figure 15 - Identification of phosphatidylcholine (PC). (A) MS spectrum of PC region. (B) ESI-MS/MS spectrum 
(HCD fragmentation) of the [M+H]+ ion of PC(34:1) (m/z 760.5848). (C) ESI-MS/MS spectrum (HCD) 
fragmentation of the [M+CH3COO]- ion of PC(34:1) (m/z 818.5908). Fragment ions characteristic for the PC class 
were highlighted in a red box. *background 
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Phosphatidylglycerols (PG) were identified in negative ion mode, as [M-H]- ions. The 
most abundant PG molecular species was found at m/z 747.5174 [PG(34:1)]. The MS/MS 
spectrum showed the abundant ion at m/z 153.9944 and 171.0061, corresponding to the 
phosphoglycerol group. The presence of these product ions allowed to confirm the presence of 
PG molecular species. It was also possible to observe the carboxylate anions of fatty acyl 
chains 16:0 (R1COO
-) at m/z 255.2326 and 18:1 (R2COO
-) at m/z 281.2482. Therefore, this PG 
species was identified as PG(34:1) [PG(16:0/18:1)]. 
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Figure 17 - Identification of phosphatidylglycerol (PG). (A) MS spectrum of PG region. (B) ESI-MS/MS 
spectrum (HCD) fragmentation of the [M-H]- ion of PG(34:1) (m/z 747.5174). Fragment ions characteristic for 
the PG class were highlighted in a red box. *background 
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Figure 15 - Identification of phosphatidylethanolamine (PE). (A) MS spectrum of PE region. (B) ESI-MS/MS 
spectrum (HCD fragmentation) of the [M+H]+ ion of PE(38:4) (m/z 768.5531). (C) ESI-MS/MS spectrum 
(HCD) fragmentation of the [M-H]- ion of PE(38:4) (m/z 766.5367). Fragment ions characteristic for the PE 
class were highlighted in a red box. *background 
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Phosphatidylinositols (PI) were identified in negative ion mode, as [M-H]- ions. The 
most abundant PI molecular species was found at m/z 885.5488 [PI(38:4)]. The MS/MS 
spectrum showed the characteristic ion at m/z 241.0111 corresponding to the 
phosphatidylinositol polar head group. Additionally, the MS/MS spectrum showed the 
abundant ion at m/z 153.9947. The presence of these product ions allowed to confirm the 
presence of PI molecular species. It was also possible to observe the carboxylate anions of 
fatty acyl chains 18:0 (R1COO
-) at m/z 283.2647 and 20:4 (R2COO
-) at m/z 303.2334. 
Therefore, this PI species could be defined as PI(38:4) [PI(18:0/20:4)]. 
 
Phosphatidylserines (PS) were identified in negative ion mode, as [M-H]- ions. The 
most abundant PS molecular species was found at m/z 810.5278 [PS(38:4)]. The MS/MS 
spectrum showed the abundant ion at m/z 152.9945. MS/MS did not show product ions formed 
due to loss of 87.0320, corresponding to serine from polar head group. The presence of these 
product ions, retention time at which these species were identified, and comparison to exact 
mass measurements allowed to confirm the presence of PS molecular species. It was also 
possible to observe the carboxylate anion of fatty acyl chain 18:0 (R1COO
-) at m/z 283.2633. 
Therefore, this PS species was identified as PS(38:4) [PG(18:0/20:4)]. 
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Figure 18 - Identification of phosphatidylinositol (PI). (A) MS spectrum of PI region. (B) ESI-MS/MS 
spectrum (HCD) fragmentation of the [M-H]- ion of PI(38:4) (m/z 885.5488). Fragment ions characteristic for 
the PI class were highlighted in a red box. *background 
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Sphingomyelins (SM) were identified in positive ion mode, as [M+H]+ ions. The most 
abundant SM molecular species was identified at m/z 703.5750 [SM(d34:1)]. The MS/MS 
spectrum showed the abundant ion at m/z 184.0730, which corresponds to the phosphocholine 
polar head group. SMs were also identified in negative ion mode, as [M+CH3COO]
- ions, 
which corresponds to a mass shift of plus 58.0055 Da in comparison with the [M+H]+ ions. 
The most abundant SM molecular species was found at m/z 761.5814. The MS/MS spectrum 
showed product ions at m/z 687.5455, formed due to neutral loss of 74.03678 Da 
(CH3COOCH3), and ions at m/z 168.0420, corresponding to the demethylated phosphocholine 
polar head group. The presence of these two types of product ions allowed to confirm the 
presence of SM molecular species. This SM species was identified as SM(d34:1). 
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Figure 19 - Identification of phosphatidylserine (PS). (A) MS spectrum of PS region. (B) ESI-MS/MS spectrum 
(HCD fragmentation) of the [M-H]- ion of PS(38:4) (m/z 810.5278). Fragment ions characteristic for the PS class 
were highlighted in a red box. *background 
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Lyso-phosphatidylcholines (LPC) were identified in positive ion mode, as [M+H]+ 
ions. The most abundant LPC molecular species was identified at m/z 496.3398 [LPC(16:0)]. 
The MS/MS spectrum showed the abundant ion at m/z 184.0727, which corresponds to the 
phosphocholine polar head group. LPC were also identified in negative ion mode, as 
[M+CH3COO]
- ions, which corresponds to a mass shift of plus 58.0055 Da in comparison 
with the [M+H]+ ions. The most abundant LPC molecular species was found at m/z 554.3460. 
The MS/MS spectrum showed product ions at m/z 687.5455, formed due to neutral loss of 
74.03678 Da (CH3COOCH3). The presence of these two types of product ions allowed to 
confirm the presence of LPC molecular species. It was also possible to observe the 
carboxylate anion of fatty acyl chain 16:0 (RCOO-) at m/z 255.2324. Therefore, this LPC 
species could be defined as LPC(16:0). 
 
 
Figure 20 - Identification of sphingomyelin (SM). (A) MS spectrum of SM region. (B) ESI-MS/MS spectrum 
(HCD fragmentation) of the [M+H]+ ion of SM(d34:1) (m/z 703.5750). (C) ESI-MS/MS spectrum (HCD) 
fragmentation of the [M+CH3COO]- ion of SM(d34:1) (m/z 761.5814). Fragment ions characteristic for the SM 
class were highlighted in a red box. *background 
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Figure 21 – Identification of lyso-phosphatidylcholine (LPC). (A) MS spectrum of LPC region. (B) ESI-MS/MS 
spectrum (HCD fragmentation) of the [M+H]+ ion of LPC(16:0) (m/z 496.3398). (C) ESI-MS/MS spectrum 
(HCD) fragmentation of the [M+CH3COO]- ion of LPC(16:0) (m/z 554.3460). Fragment ions characteristic for 
the LPC class were highlighted in a red box. *background 
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Table 4 – Phospholipid molecular species identified in THP-1 macrophages. 
Lipid species (C:N) 
Calculated 
m/z  
Observed 
m/z  
Error 
(ppm) 
Fatty acyl chains (C:N) Formula 
LPC identified as  [M+CH3COO]- 
LPC(16:0) 554,3455 554,3458 0,4755 16:0 C26H53NO9P 
LPC(18:0) 582,3770 582,3771 0,1904 18:0 C28H57NO9P 
LPC(18:1) 580,3614 580,3614 0,0639 18:1 C28H55NO9P 
LPE  identified as  [M-H]- 
LPE(16:0) 452,2779 452,2777 -0,5021 16:0 C21H43NO7P 
LPE(18:0) 480,3093 480,3090 -0,5484 18:0 C23H47NO7P 
LPE(18:1) 478,2931 478,2934 0,6425 18:1 C23H45NO7P 
LPE(18:2) 476,2774 476,2777 0,6402 18:2 C23H43NO7P 
LPE(20:3) 502,2939 502,2934 -1,1113 20:3 C25H45NO7P 
LPE(20:4) 500,2778 500,2777 -0,0800 20:4 C25H43NO7P 
LPE(20:5) 498,2619 498,2621 0,3767 20:5 C25H41NO7P 
LPE(22:5) 526,2933 526,2934 0,0517 22:5 C27H45NO7P 
LPE(22:6) 524,2774 524,2777 0,5377 22:6 C27H43NO7P 
PC identified as  [M+CH3COO]- 
PC(30:0) 764,5442 764,5447 0,6631 14:0/16:0 C40H79NO10P 
PC(30:1) 762,5285 762,5287 0,2465 14:0/16:1 and 14:1/16:0 C40H77NO10P 
PC(32:0) 792,5755 792,5753 -0,2333 16:0/16:0 C42H83NO10P 
PC(32:1) 790,5598 790,5584 -1,7588 14:0/18:1 and 16:0/16:1 C42H81NO10P 
PC(32:2) 788,5442 788,5434 -0,9330 16:0/16:2 and 14:0/18:2 C42H79NO10P 
PC(34:1) 818,5911 818,5888 -2,8451 16:0/18:1 C44H85NO10P 
PC(34:2) 816,5755 816,5755 0,0696 16:0/18:2 and 16:1/18:1 C44H83NO10P 
PC(34:3) 814,5598 814,5601 0,3822 16:0/18:3 and 16:1/18:2 C44H81NO10P 
PC(34:4) 812,5442 812,5418 -2,9035 ** C44H79NO10P 
PC(36:1) 846,6224 846,6196 -3,2861 18:0/18:1 C46H89NO10P 
PC(36:2) 844,6068 844,6063 -0,4993 18:1/18:1 C46H87NO10P 
PC(36:3) 842,5911 842,5909 -0,2680 16:0/20:3 and 18:1/18:2 C46H85NO10P 
PC(36:4) 840,5755 840,5728 -3,1724 16:0/20:4 and 16:1/20:3 C46H83NO10P 
PC(36:5) 838,5598 838,5590 -0,9799 16:0/20:5 and 16:1/20:4 C46H81NO10P 
PC(36:6) 836,5442 836,5422 -2,2891 16:1/20:5 C46H79NO10P 
PC(38:3) 870,6224 870,6213 -1,2845 16:0/22:3, 18:0/20:3, 18:1/20:2 and 18:2/20:1 C48H89NO10P 
PC(38:4) 868,6068 868,6041 -3,0474 18:0/20:4 C48H87NO10P 
PC(38:5) 866,5911 866,5913 0,1832 18:1/20:4 C48H85NO10P 
PC(38:6) 864,5755 864,5745 -1,0878 16:0/22:6 C48H83NO10P 
PC(38:7) 862,5598 862,5587 -1,3147 18:0/22:7 C48H81NO10P 
PC(40:4) 896,6381 896,6349 -3,4845 18:1/22:3 and 18:2/22:2 C50H91NO10P 
PC(40:5) 894,6224 894,6224 -0,0355 ** C50H89NO10P 
PC(40:6) 892,6068 892,6043 -2,7152 18:1/22:5 C50H87NO10P 
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 Table 4 (Cont.) 
Lipid species (C:N) 
Calculated 
m/z  
Observed 
m/z  
Error 
(ppm) 
Fatty acyl chains (C:N) Formula 
PC(40:7) 890,5911 890,5897 -1,5679 18:1/22:6 C50H85NO10P 
PC(O-28:0) 722,5336 722,5335 -0,1785 ** C38H77NO9P 
PC(O-30:0) 750,5649 750,5634 -1,9413 14:0/16:0 and 16:0/14:0 C40H81NO9P 
PC(O-30:1)/PC(P-30:0) 748,5492 748,5483 -1,2073 14:0/16:1 and 16:0/14:1 C40H79NO9P 
PC(O-32:0) 778,5962 778,5947 -1,9795 ** C42H85NO9P 
PC(O-32:1)/PC(P-32:0) 776,5805 776,5792 -1,7513 16:0/16:1 and 16:1/16:0 C42H83NO9P 
PC(O-34:1)/PC(P-34:0)  804,6118 804,6093 -3,1557 16:0/18:1 and 18:1/16:0 C44H87NO9P 
PC(O-34:2)/PC(P-34:1)  802,5962 802,5944 -2,2724 16:0/18:2, 16:1/18:1, 18:1/16:1 and 18:2/16:0 C44H85NO9P 
PC(O-34:3)/PC(P-34:2)  800,5805 800,5808 0,3135 18:2/16:1 C44H83NO9P 
PC(O-36:1)/ PC(P-36:0)  832,6431 832,6432 0,0440 18:1/18:0 C46H91NO9P 
PC(O-36:2)/PC(P-36:1)  830,6275 830,6252 -2,7152 18:1/18:1 C46H89NO9P 
PC(O-36:3)/PC(P-36:2)  828,6118 828,6107 -1,3701 18:1/18:2, 18:2/18:1 and 20:3/16:0 C46H87NO9P 
PC(O-36:5)/PC(P-36:4)  824,5805 824,5796 -1,1001 20:4/16:1 C46H83NO9P 
PC(O-38:4)/ PC(P-38:3) 854,6275 854,6247 -3,2888 20:4/18:0 and 20:3/18:1 C48H89NO9P 
PC(O-38:5)/PC(P-38:4)  852,6118 852,6102 -1,9716 20:4/18:1 C48H87NO9P 
PC(O-38:6)/PC(P-38:5)  850,5962 850,5943 -2,1765 16:1/22:5, 18:0/20:6 and 22:6/16:0 C48H85NO9P 
PC(O-40:5)/PC(P-40:4) 880,6431 880,6408 -2,6434 20:4/20:1 C50H91NO9P 
PC(O-42:4)/PC(P-42:3)  910,6901 910,6882 -2,0772 20:4/22:0 C52H97NO9P 
PC(O-42:5)/PC(P-42:4)  908,6744 908,6745 0,0779 ** C52H95NO9P 
PC(P-32:1)  774,5649 774,5634 -1,9079 16:1/16:1 C42H81NO9P 
PC(P-36:5)  822,5649 822,5667 2,1702 20:5/16:1 C46H81NO9P 
PC(P-38:6)  848,5805 848,5795 -1,1941 18:1/20:5 and 18:0/20:6 C48H83NO9P 
PC(P-40:6)  876,6118 876,6099 -2,2685 ** C50H87NO9P 
PE identified as  [M-H]- 
PE(32:0) 690,5050 690,5074 3,4798 * C37H73NO8P 
PE(32:1) 688,4911 688,4917 0,9429 16:0/16:1 C37H71NO8P 
PE(34:1) 716,5223 716,5230 1,0321 16:1/18:0 and 16:0/18:1 C39H75NO8P 
PE(34:2) 714,5077 714,5074 -0,4095 16:1/18:1 and 16:0/18:2 C39H73NO8P 
PE(36:1) 744,5542 744,5543 0,1327 18:0/18:1 C41H79O8NP 
PE(36:2) 742,5372 742,5387 1,9930 18:1/18:1 and 18:0/18:2 C41H77O8NP 
PE(36:5)  736,4904 736,4917 1,8313 16:0/20:5 and 16:1/20:4 C41H71O8NP 
PE(38:3)  768,5524 768,5543 2,5380 18:0/20:3 C43H79NO8P 
PE(38:4)  766,5379 766,5367 -1,5655 18:0/20:4 C43H77O8NP 
PE(38:5) 764,5221 764,5230 1,2435 18:1/20:4 and 18:0/20:5 C43H75NO8P 
PE(38:6)  762,5087 762,5074 -1,6821 16:0/22:6 and 18:1/20:5 C43H73O8NP 
PE(40:4) 794,5687 794,5700 1,6131 18:2/22:2 C45H81NO8P 
PE(40:5) 792,5531 792,5543 1,5114 ** C45H79O8NP 
PE(40:6) 790,5375 790,5387 1,4475 18:0/22:6 C45H77O8NP 
PE(O-32:2)/PEp(32:1) 672,4966 672,4968 0,3567 16:1/16:1 C37H71O7NP 
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 Table 4 (Cont.) 
Lipid species (C:N) 
Calculated 
m/z 
Observed 
m/z 
Error 
(ppm) 
Fatty acyl chains (C:N) Formula 
PE(O-32:3)/PEp(32:2)  670,4818 670,4812 -0,9665 ** C37H69O7NP 
PE(O-34:2)/PE(P-34:1)  700,5281 700,5281 0,0531 16:1/18:1, 16:0/18:2, 18:1/16:1 and 18:2/16:0 C39H75NO7P 
PE(O-34:3)/PE(P-34:2) 698,5116 698,5125 1,2949 18:2/16:1 C39H73NO7P 
PE(O-34:4)/PE(P-34:3) 696,4978 696,4968 -1,4398 18:3/16:1 and 18:1/16:2 C39H71NO7P 
PE(O-34:5)/PEp(34:4) 694,4799 694,4812 1,8002 20:4/14:1 C39H69O7NP 
PE(O-36:2)/PE(P-36:1) 728,5582 728,5594 1,7134 18:1/18:1 C41H79NO7P 
PE(O-36:3)PE(P-36:2) 726,5433 726,5438 0,6971 18:1/18:2 and 18:2/18:1 C41H77NO7P 
PE(O-36:4)/PE(P-36:3) 724,5275 724,5281 0,8448 ** C41H75NO7P 
PE(O-36:5)/PE(P-36:4) 722,5118 722,5125 0,8599 20:4/16:0 C41H73NO7P 
PE(O-36:6)/PEp(36:5) 720,4963 720,4968 0,7853 20:5/16:1 C41H71O7NP 
PE(O-38:5)/PE(P-38:4) 750,5425 750,5438 1,6653 20:3/18:2, 20:4/18:1, 20:5/18:0 and 22:4/16:1 C43H77NO7P 
PE(O-38:6)/PE(P-38:5) 748,5264 748,5281 2,3491 20:4/18:2, 20:5/18:1 and 22:4/16:1 C43H75NO7P 
PE(O-38:7)/PEp(38:6) 746,5121 746,5125 0,4529 22:6/16:1 C43H73O7NP 
PE(O-40:4)/PE(P-40:3) 780,5899 780,5907 1,0527 ** C45H83NO7P 
PE(O-40:5)/PE(P-40:4) 778,5731 778,5751 2,5602 ** C45H81NO7P 
PE(O-40:6)/PE(P-40:5)  776,5599 776,5594 -0,5948 ** C45H79NO7P 
PE(O-40:7)/PEp(40:6)  774,5422 774,5438 2,0109 ** C45H77O7NP 
PE(O-40:8)/PEp(40:7)  772,5262 772,5281 2,5021 22:6/18:2 C45H75O7NP 
PE(O-42:5)/PEp(42:4) 806,6038 806,6064 3,1809 20:3/22:2 C47H85O7NP 
PE(O-42:6)/PEp(42:5) 804,5902 804,5907 0,6666 20:4/22:2 C47H83O7NP 
PE(O-42:7)/PEp(42:6) 802,5742 802,5751 1,0630 20:5/22:4 C47H81O7NP 
PG identified as  [M-H]- 
PG(32:1) 719,4850 719,4863 1,8758 16:0/16:1 and 14:0/18:1 C38H72O10P 
PG(34:1)  747,5172 747,5176 0,5169 16:0/18:1 C40H76O10P 
PG(34:2) 745,5005 745,5020 1,8998 16:1/18:1 and 16:0/18:2 C40H74O10P 
PG(36:1) 775,5486 775,5489 0,3628 * C42H80O10P 
PG(36:2) 773,5309 773,5333 3,0111 18:1/18:1 C42H78O10P 
PG(36:3) 771,5165 771,5176 1,3925 ** C42H76O10P 
PG(36:4) 769,4994 769,5020 3,2777 ** C42H74O10P 
PG(38:4) 797,5318 797,5333 1,8597 18:1/20:3 C44H78O10P 
PG(38:5) 795,5172 795,5176 0,5386 * C44H76O10P 
PG(38:6) 793,5003 793,5020 2,1095 16:0/22:6 and 18:0/20:6 C44H74O10P 
PG(38:7) 791,4861 791,4863 0,2925 16:1/22:6 C44H72O10P 
PG(40:7) 819,5161 819,5176 1,8256 18:1/22:6 C46H76O10P 
PG(42:10)  841,5016 841,5020 0,4182 20:4/22:6 C48H74O10P 
PG(44:12) 865,5006 865,5020 1,5970 22:6/22:6 C50H74O10P 
PI identified as  [M-H]- 
PI(32:1) 807,5019 807,5024 0,5280 16:0/16:1 C41H76O13P 
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 Table 4 (Cont.) 
Lipid species (C:N) 
Calculated 
m/z 
Observed 
m/z 
Error 
(ppm) 
Fatty acyl chains (C:N) Formula 
PI(34:1) 835,5334 835,5337 0,3223 16:0/18:1 and 16:1/18:0 C43H80O13P 
PI(34:2) 833,5161 833,5180 2,2643 16:0/18:2 and 16:1/18:1 C43H78O13P 
PI(36:1) 863,5630 863,5650 2,2416 18:0/18:1 C45H84O13P 
PI(36:2) 861,5489 861,5493 0,5287 18:1/18:1, 18:0/18:2 and 16:0/20:2 C45H82O13P 
PI(36:3) 859,5336 859,5337 0,0875 ** C45H80O13P 
PI(36:4) 857,5174 857,5180 0,6807 16:0/20:4 C45H78O13P 
PI(36:5) 855,5005 855,5024 2,1891 16:0/20:5 C45H76O13P 
PI(38:4) 885,5487 885,5493 0,6412 18:0/20:4 C47H82O13P 
PI(38:5) 883,5309 883,5337 3,1067 18:1/20:4 and 18:0/20:5 C47H80O13P 
PI(38:6) 881,5163 881,5180 1,9126 16:0/22:6 C47H78O13P 
PI(40:3) 915,5946 915,5963 1,8068 ** C49H88O13P 
PI(40:4) 913,5792 913,5806 1,5046 18:0/22:4 C49H86O13P 
PI(40:5) 911,5656 911,5650 -0,6823 18:0/22:5 C49H84O13P 
PI(40:6) 909,5473 909,5493 2,2401 18:0/22:6 and 18:1/22:5 C49H82O13P 
PI(40:7) 907,5320 907,5337 1,8724 18:1/22:6 C49H80O13P 
PS identified as  [M-H]- 
PS(32:1) 732,4812 732,4816 0,5496 16:0/16:1 C38H71NO10P 
PS(34:1) 760,5112 760,5129 2,2047 16:0/18:1 and 16:1/18:0 C40H75NO10P 
PS(34:2) 758,4955 758,4972 2,2935 16:0/18:2 C40H73NO10P 
PS(36:1) 788,5433 788,5442 1,1095 18:0/18:1 C42H79NO10P 
PS(36:2) 786,5263 786,5285 2,8574 18:0/18:2 C42H77NO10P 
PS(36:3) 784,5115 784,5129 1,6923 ** C42H75NO10P 
PS(36:4) 782,4969 782,4972 0,4135 ** C42H73NO10P 
PS(38:3) 812,5417 812,5442 3,0853 18:0/20:3 C44H79NO10P 
PS(38:4) 810,5289 810,5285 -0,5074 18:0/20:4 C44H77NO10P 
PS(38:5) 808,5129 808,5129 -0,0777 18:2/20:3 C44H75NO10P 
PS(40:6) 834,5270 834,5285 1,8138 18:0/22:6 C46H77NO10P 
SM identified as  [M+CH3COO]- 
SM(d32:1) 733,5496 733,5492 -0,5039 - C39H78N2O8P 
SM(d34:1) 761,5809 761,5799 -1,2386 - C41H82N2O8P 
SM(d34:2) 759,5652 759,5645 -0,9840 - C41H80N2O8P 
SM(d36:1) 789,6122 789,6107 -1,8237 - C43H86N2O8P 
SM(d36:2) 787,5965 787,5957 -1,0015 - C43H84N2O8P 
SM(d38:1) 817,6435 817,6414 -2,5599 - C45H90N2O8P 
SM(d40:1) 845,6748 845,6738 -1,1689 - C47H94N2O8P 
SM(d40:2) 843,6591 843,6599 0,8738 - C47H92N2O8P 
SM(d42:1) 873,7061 873,7058 -0,3445 - C49H98N2O8P 
SM(d42:2) 871,6904 871,6884 -2,3429 - C49H96N2O8P 
59 
 
 Table 4 (Cont.) 
Lipid species (C:N) 
Calculated 
m/z 
Observed 
m/z 
Error 
(ppm) 
Fatty acyl chains (C:N) Formula 
SM(d42:3) 869,6748 869,6729 -2,1697 - C49H94N2O8P 
SM(d44:2) 899,7217 899,7207 -1,1302 - C51H100N2O8P 
Legend: C – carbons; N – number of double bonds; *identified based on exact mass measurements; ** no FA acyl-chain fragments observed 
 
III.1.2.2. Changes in macrophage phospholipidome induced by canonical M1 and M2 
stimuli 
As a first approach to assess the effects of M1 and M2 polarization on the 
phospholipidome of macrophages, we have compared relative abundances of the eight PL 
classes identified (Figure 22A). M1 macrophages showed an increase in the relative 
abundance of PC (p<0.05), while LPE displayed a non-significant tendency to increase. The 
relative abundances of LPC, PG and SM were non-significantly lower, in comparison to the 
control group. As for M2, there was a significant increase in the total relative amount of PC 
(p<0.001) and a significant decrease in the total relative amount of PS (p<0.01). PS species are 
known for their anti-inflammatory properties [145]. In this sense, we would expect PS species 
to increase upon M2 polarization. However, the adaptation of macrophages to M2 stimuli 
might involve an increase in consumption of PS species, rather than an increase in their 
synthesis, not allowing for PS levels to be restituted. Also, we did not identify nor quantify 
oxidized PS (oxPS) which have been recently highlighted for their anti-inflammatory/pro-
resolving properties [146]. Furthermore, despite not being statistically significant, M2 
macrophages displayed higher relative abundances of PI and SM classes, compared to the non-
stimulated cells, while relative abundances of LPC, LPE, PE and PG class appeared to be 
lower.  
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Figure 22 – Changes in PL class and structure observed in M1 (24h, LPS+IFN-γ) and M2 (48h, IL-4/IL-13). 
The different graphs represent total amounts of (A) different PL classes, (B) PL-composing FA differing in 
total number of carbons, (C) C18 FA-containing PL species, (D) AA-containing PL species, (E) PL-composing 
FA differing in the number of double bonds. *, **, ****, Statistical significance (p<0.05, p<0.01, p<0.0001). 
Error bars represented as mean±S (n=5). 
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We have also looked at the chain lengths of FA constituting the different PL (Figure 
22B). Compared to M0 controls, M1 cells showed a significant increase in species with 36 
carbons, accompanied by a decreasing trend for 32 carbon-containing PL. Species containing 
36 carbons are mainly composed of two C18 FA, which were indeed found to increase in M1 
macrophages (Figure 23). ELOVL 6 is an elongase responsible for synthesizing C18 from 
C16 [51]. In macrophages, ELOVL6 has been found increased in M1-induced BMDM 
[51,52], and to contribute to foam cell formation and atherosclerosis [51]. Saito et al observed 
that when macrophages from ELOVL6-.- mice were transplanted to an atherosclerotic mice 
model, aortic atherosclerotic lesion areas and infiltration of macrophages were significantly 
smaller. This suggests a pro-inflammatory role for ELOVL6 in which could be possibly 
relating with the C36 increase observed in our work. On the other hand, M2 macrophages 
showed higher relative abundance of PL containing 34 carbons, whereas a decrease in PL with 
36 carbons was suggested. 
 
Regarding FA unsaturation degree (Figure 22C) M1 activation decreased the relative 
amount of PL species containing MUFA (mono-unsaturated fatty acids; p<0.05). We also 
observed a tendency to decrease the relative abundance of PL containing SFA (saturated fatty 
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Figure 23 – Changes in C18-containing PL species in M1 and M2 macrophages. **, statistically 
significance (p<0.01). 
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acids). The amount of PL containing PUFA in cellular membrane is an effective modulator of 
membrane fluidity [147]. An increase in PL containing PUFA suggests membranes to be more 
fluid. Decrease in MUFA and a tendency to increase PUFA are possibly associated with an 
increased activity from stearoyl-CoA desaturases (SCD). They have been previously reported 
in M1 macrophages [49]. PUFA are also known inflammatory mediators [148]. Among PUFA 
species, arachidonic acid (AA) is well known for its involvement in inflammation. For 
instance, AA acts as precursor for the synthesis of eicosanoids, which can display either pro- 
or anti-inflammatory activity [77]. In M1 macrophages, we observe an increase in PL species 
containing AA (Figure 24). M1 macrophages are characterized by production of 
prostaglandins, known members of the eicosanoid family [149]. It is also known that COX-2 
is a hallmark of M1 polarization [150]. Therefore, increase in AA might be the result of its 
extensive use to produce prostaglandins. Future studies should evaluate COX-2 activity, as 
well as characterize produced prostaglandins and other eicosanoids.  In M2 macrophages, 
there were no statistically significant changes in the number of unsaturations. We observed a 
tendency to increase the relative amount of PL species containing MUFA or two double bonds 
in their structure.  
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Figure 24 – Changes in AA-containing PL species in M1 and M2 macrophages. **** statistical significance 
(p<0.0001) 
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 To further analyse the data and reveal individual lipid species differing consistently 
upon M1 and M2 polarization, multivariate analysis was applied. All macrophage subsets 
tended to cluster away from each other in the PCA scores scatter plots (Figure 25A,B), 
although the separation between M0 and M1 macrophages (Figure 25A) was less clear than 
that of M0 and M2 cells (Figure 25B). PLS-DA (Figure 25C,D), which maximizes separation 
between pre-defined classes, showed good discriminant ability  in both cases, as indicated by 
the high Q2 values obtained. In each case, the top 20 variables with higher VIP values, 
reflecting the most important lipid species accounting for macrophage phenotypic distinction, 
are shown in Figure 25E,F.  
To validate the results of multivariate analysis and assess the magnitude of variations, 
the relative amounts of individual lipid species were calculated based on chromatographic 
peak areas, normalized to the total area of all identified species. The variations with an effect 
size (ES) greater than 0.8 (considered to be large according to Berben et al. [151]) were 
represented in Volcano plots (Figure 26A,B). In general, there was good agreement with the 
multivariate analysis results. The levels of the 20 species with higher magnitude of variation 
(ES) in M1 and in M2 macrophages relative to their respective controls were represented in 
boxplots. For M1 macrophages, the top 20 variations (Figure 27) comprised: i) increases in 9 
PCs, 3 LPEs, 1 PE, 1 PE plasmalogen, 1 PI and 1 SM, ii) decreases in 2 LPCs, 1 PE 
plasmalogen and 1 PG. On the other hand, M2 macrophages displayed as the main 20 top 
variations (Figure 28): i) increases in 3 PCs, 4 PE plasmalogens and 2 PIs, ii) decreases in 1 
PE plasmalogen, 7 PGs and 2 PIs. 
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Figure 25 – Multivariate analysis of LC-MS data collected for M1 (LPS/IFN-γ, 24h) and M2 (IL-4/IL-13, 
48h) macrophages. (A),(B) PCA scores scatter plot; (C),(D) PLS-DA scores scatter plot obtained for 
pairwise comparisons between M1 and M2 cells and their respective controls; (E), (F) Twenty PL species 
with higher VIP values i.e. higher importance to PLS-DA discrimination. 
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Figure 26 (A) and (B) Volcano Plots representing the PL species with large magnitude (|ES|>0.8) in M1 (LPS/IFN-γ, 
24h) and M2 (IL-4/IL-13, 48h) macrophages, relatively to respective controls. The 20 species with the highest |ES| are 
highlighted in green squares. (C) Schematic representation of similarity between the top-20 varying PL species in M1 
and M2 macrophages. (D) Pie chart representing the % of common increases, common decreases and discrepant 
variations between PL data subsets collected for M1 and M2 macrophages 
22%
21%57%
M1 vs. M2
Common Increases
Common Decreases
Different variations
0
1
2
3
4
5
6
7
-10 -5 0 5 10
-l
o
g
(p
-v
a
lu
e
)
Effect Size
Volcano Plot - M1
C 
A B 
0
0,5
1
1,5
2
2,5
3
3,5
4
4,5
-6 -4 -2 0 2 4 6 8
-l
o
g
(p
-v
a
lu
e
)
Effect Size
Volcano Plot - M2
PE(O-42:6)/PE(P-42:5)  
PI(36:2)  
PC(36:2)  
PC(40:5)  
PE(O-34:5)/PE(P-34:4) 
) 
PG(42:10)  
PS(36:1)  
PS(38:3)  
PC(38:4)  
PC(38:3)  
LPC(16:0)  
SM(d44:2)  
PG(32:1)  
PE(O-34:5)/PE(P-34:4)  
D 
66 
 
Several phosphatidylcholine (PC) species varied significantly upon M1 and M2 
polarization. PCs are the major class of PL in mammalian cells [152]. They are a key 
component of cell membranes and seem to help regulate membrane fluidity. When PC/PE 
ratio is elevated, membranes tend to become more fluid [153]. In this sense, macrophage 
activation seems to induce changes in membrane fluidity. Interestingly, the increase in 
PC(34:1) was one of the most important variations during M1 polarization. PC(34:1) is a 
ligand of PPAR-α [154], which is responsible for the regulation of several inflammation-
related genes.  
 
 
LPC(16:0) LPC(18:1) LPE(20:3) LPE(20:4) LPE(20:5) 
PC(34:3) PC(36:1) PC(36:3) PC(36:4) PC(38:3) 
PC(38:4) PC(38:5) PC(40:4) PC(40:5) PE(40:4) 
PE(O-34:5)/PE(P-34:4) PG(32:1) PI(40:7) SM(d44:2) PE(O-40:8)/PE(P-40:7) 
Figure 27 - Boxplots showing the levels of the top-20 varying PL species in M1 macrophages (24h, 
LPS/IFN-γ). ▀ M0; ▀ M1. 
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In agreement with previous profiling of THP-1-derived macrophages [132], LPC(18:1) 
was down-regulated in M1 macrophages, while several LPEs, including LPE(20:4) and 
LPE(20:5), were up-regulated. This increase in LPE species suggests increased hydrolysis of 
PE species. PLA2 is responsible for hydrolysis of PLs, and has previously been reported to be 
up-regulated in M1-like macrophages [69]. Therefore, increase in these LPE species might be 
the result of increased PLA2 activity, an hypothesis which requires further verification.  
Although little changes were observed in the PE class, down-regulation of PE(O-
32:2)/PE(P-32:1), PE(O-36:2)/PE(P-36:1) and PE(40:8)/PE(P40:7), together with up-
regulation of PE(O-34:5)/PE(P-34:4)  had significant impact on M1 polarization. M2 
macrophages also displayed increased PE(O-34:5)/PE(P-34:4), along with some other 
PC(36:1) PC(36:2) PC(40:5) PC(O-28:0) PE(O-34:5)/PE(P-34:4) 
PE(O-36:6)/PE(P-36:5) PE(O-42:6)/PE(P-42:5) PE(O-42:7)/PE(P-42:6) PG(34:1) PG(34:2) 
PG(36:4) PG(38:7) PG(40:7) PG(42:10) PG(44:12) 
PI(36:2) PI(40:5) PS(36:1) PS(38:3) PS(38:4) 
Figure 28 – Boxplots showing the levels of the top-20 varying PL species in M2 macrophages (48h, IL-
4/IL-13). ▀ M0; ▀ M2. 
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variations in this class of PL, the ethanolamine plasmalogens. These species display a vinyl 
ether linkage at the sn-1 position. Ethanolamine plasmalogens are more predominant 
plasmalogen class in most mammalian cells, representing 50% of PE species in immune cells 
[155]. The unique biological characteristics of ethanolamine plasmalogens have been 
associated with their key biophysical properties, such as membrane fluidity, fusion tendency 
and thickness [156,157]. For instance, the vinyl ether linkage at the sn-1 position of 
plasmalogens allows the proximal regions of the sn-1 and sn-2 chains to become parallel, 
diminishing distances between the carbons of these chains. This enhances condensation and 
ordering of PL in the membrane, decreasing membrane fluidity [158]. They tend to 
accumulate in lipid raft microdomains and are essential to maintain the stability of these 
structures [159,160], which suggests a possible role in cell signaling, as microdomains are 
essential for cell communication. Plasmalogens were also reported to have an antioxidant role 
[161,162]. However, their signalling effect is far from being fully elucidated. 
Several PG species were altered upon macrophage polarization, being down-regulated 
in M2 macrophages. However, little is known about PG biological activity, and, to the extent 
of our knowledge, the role of PG in inflammation is yet to be explored. Alterations in PI 
species were also identified. PIs are often associated with cell signalling [163]. For instance, 
they act as substrates in the formation of PIP for PI3K pathway [164]. This pathway is 
involved in the regulation of inflammatory mediators, such as TNF-α. These pro-inflammatory 
mediators are up-regulated in M1 activated macrophages, underlying a possible link to the 
levels of certain PIs in activated macrophages. 
Notably, out of the top-20 variations only 3 were common to M1 and M2 phenotypes, 
namely the increases in PC(36:1), PC(40:5) and PE(O-34:5)/PE(P-34:4) (Figure 26C). By 
performing a broader comparison of variations with |ES| > 0.8 in M1 or M2 macrophages 
relative to resting cells, we found that 57% of PL changes were distinct depending on the 
polarization stimulus (Figure 26D). On the other hand, 43% of changes were commonly seen 
in M1 and M2 macrophages, although possibly at varying extensions. Therefore, it may be 
inferred that while some changes reflect general activation-induced remodelling of cellular 
phospholipids, others are specific to the polarization stimulus employed. 
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Altogether, the significant variations herein observed for several PL molecular species 
might arise from a wide array of adaptive mechanisms adopted by macrophages in response to 
polarization stimuli. The different changes between the PL profile of M1 and M2 macrophages 
might be associated with the different functions that differentially polarized macrophages 
acquire. 
 
III.2. Macrophage responses to flavonoids 
III.2.1. Cell viability  
 To determine the maximal flavonoids concentrations that could be used without 
significantly decreasing cell viability, THP-1 macrophages were treated with each flavonoid 
for 24h, at concentrations ranging from 0 to 200 µM. 
The results obtained for quercetin are shown in Figure 29. Cell viability did not 
decrease at concentrations up to 60 µM. However, at 80 µM and above, there were significant 
decreases in macrophage viability. Therefore, the quercetin concentration chosen for 
subsequent assays was 60 µM. 
 
Figure 29 - Cell viability assessed by the Alamar Blue reduction assay. THP-1 macrophages were incubated with 
0-200 µM of quercetin for 24 hours. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, compared to control group 
(K-). Error bars represented as mean±SD (n=5). 
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Figure 30 shows the viability results for naringin exposure. None of the concentrations 
tested (up to 200 µM) significantly affected cell viability, meaning that naringin was not toxic 
to cells during the 24h incubation period. Thus, the 200 µM concentration was selected for 
subsequent experiments.  
 
 Upon exposure to naringenin, cell viability decreased significantly at 150 and 200 µM 
flavonoid concentration, while the % viable cells remained high at lower concentrations 
(Figure 31). Accordingly, a concentration of 100 µM naringenin was used in the following 
assays. 
Figure 30 - Cell viability assessed by the Alamar Blue reduction assay. THP-1 macrophages were incubated with 
0-200 µM of naringin for 24 hours. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, compared to control group 
(K-). Error bars represented as mean±SD (n=5). 
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Figure 31 - Cell viability assessed by the Alamar Blue reduction assay. THP-1 macrophages were incubated with 
0-200 µM of naringenin for 24 hours. *p<0.05, **p<0.01, ***p<0.001, ****p<0.0001, compared to control group 
(K-). Error bars represented as mean±SD (n=5). 
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 III.2.2. Production of pro- and anti-inflammatory cytokines 
To evaluate the immunomodulatory activity of flavonoids, we measured their effect on 
the production of cytokines by resting (M0) and pre-polarized M1 macrophages. The results 
are shown in Figure 32. The pro-inflammatory mediator TNF-α decreased in M1 pre-
polarized macrophages with all flavonoid treatments, although not reaching statistical 
significance in the case of quercetin. Also, treatment of M0 macrophages with naringin and 
naringenin led to very low TNF-α in these cells. The levels of IL-1β, another major pro-
inflammatory cytokine, showed a similar variation pattern, characterized by a non-significant 
but consistent decrease in the culture medium of all flavonoid-treated pre-polarized 
macrophages. The inflammatory cytokine IL-6 also decreased in all treated M1 macrophages, 
whereas CXCL10 remained very high after M1 polarization and showed non-significant 
decreasing trends in M0 cells incubated with quercetin and naringenin. As for the anti-
inflammatory cytokines evaluated, IL-1RA and CCL17, only the latter showed a significant 
up-regulation upon treatment of M1-polarized macrophages with naringenin. 
The results described above generally agree with the existing literature, corroborating 
the anti-inflammatory action of these flavonoids. Pre-treatment with quercetin was reported to 
attenuate the production of TNF-α, IL-1β and IL-6 upon LPS stimulation [105]. Moreover, it 
could reduce basal levels of NF-κB activation, a downstream outcome of TLR4 induction, 
which regulates the transcription of TNF-α, IL-1β, COX-2, IL-6 and IL12p40 [165]. Naringin 
(at 100 and 200 µM) was also previously seen to decrease TNF-α, IL-6, COX-2 and iNOS 
levels in M1 macrophages [112,166], with similar results having been described for naringenin 
[104]. However, our results additionally showed that naringenin could up-regulate the 
production of an anti-inflammatory mediator, CCL17, which argues in favour of its potential 
role in the resolution of inflammation. 
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Figure 32 – Changes in the profile of different cytokines quantified in the culture medium of M0 and M1 pre-
polarized macrophages after exposure to quercetin, naringin and naringenin. M0 macrophages incubated with each 
flavonoid for 48h. M1 pre-polarized macrophages incubated with each flavonoid for 24h (after 24h incubation with 
LPS/IFN-γ). (A) TNF-α; (B) IL-6; (C)CXCL10; (D) IL-1β; (E) CCL17; (F) IL-1RA. *, Statistical significance 
(p<0.05). Error bars represented as mean±SD (n=3). 
TNF-α IL 6 IL-10 
IL-1β CCL17 IL-1  
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III.2.3. Quercetin-induced changes in macrophage phospholipidome 
In the first instance, overall changes in the different PL classes were inspected (Figure 
33A). A 24/48h incubation with quercetin (60 µM) caused increases in total levels of PC in 
both M0 and pre-polarized M1 macrophages. On the other hand, total PE and SM decreased 
upon quercetin exposure. The total length of FA in PLs also changed with quercetin treatment 
(Figure 33B). Species containing 38 carbons significantly increased in treated M0 and pre-
polarized M1 macrophages. An increase was also seen for 36 carbon-containing species in 
treated M0 macrophages, while shorter 34-carbon containing PL decreased. 
The up-regulation of PL containing 36 and 38 carbons suggests an increase in C18 and 
C20 FAs. As already mentioned, C18 results from elongation of C16 FA species and C18 
levels were indeed increased upon quercetin treatment (Figure 33C). This alteration may arise 
from an increase in ELOVL6 activity [167], thus leading to the preferential generation of 
C18/C18 or C18/C20 instead of the C16/C18 generally observed in PL-34. An increase in C20 
might result from an increased consumption and turnover of arachidonic acid (AA). AA is a 
very long chain FA with an important role in modulating inflammation [77]. AA is used to 
produce eicosanoids with pro- and anti-inflammatory properties. As quercetin displays anti-
inflammatory activity, it can be postulated that generation of anti-inflammatory eicosanoids 
can arise from flavonoid stimulation. Indeed, we observed that PL species containing AA 
increased in both M0 and M1 macrophages exposed to quercetin, compared to control group, 
which corroborates our hypothesis (Figure 33D). 
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Figure 33 - Changes in PL class and structure observed in M0 macrophages treated with quercetin (60 µM) for 48h, and in pre-
polarized M1 macrophages (24h, LPS+IFN-γ) subjected to 24h incubation with quercetin (60 µM). The different graphs 
represent total amounts of (A) different PL classes, (B) PL-composing FA differing in total number of carbons, (C) C18 FA-
containing PL species, (D) AA-containing PL species, (E) PL-composing FA differing in the number of double bonds. *, **, 
****, Statistical significance (p<0.05, p<0.01, p<0.0001). Error bars represented as mean±S (n=5). 
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To further assess quercetin effects on the macrophage lipidome, PCA and PLS-DA 
were applied to data matrices built from LC-MS data. The four groups are well separated in 
the resulting PCA scores scatter plot (Figure 34A). PC1 clearly distinguishes cellular subsets 
according to their primary polarization states (M0 and M1), while PC2 reflects flavonoid 
treatment. Indeed, quercetin-treated macrophages are located in positive PC2 and their 
respective controls in negative PC2. Interestingly, the separation along this axis between M0 
cells and their quercetin-treated counterparts seems much larger than that between quercetin-
treated M1 macrophages and M1 controls (corresponding, respectively, to cells stimulated 
with LPS/IFN for 24h and then exposed to the flavonoid or left to rest in new medium, for 
another 24h). The distinction between untreated and quercetin-treated cells was further 
verified through PLS-DA, which produced robust discriminations (Figure 34B,C). The 
corresponding VIP scores plots (Figure 34D,E) then revealed the lipid species displaying 
more important contributions for the multivariate models. 
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Figure 34 - Multivariate analysis of LC-MS data collected for M0 and M1 pre-polarized macrophages 
exposed to quercetin (60 µM). (A) PCA scores scatter plot; (B),(C) PLS-DA scores scatter plot 
obtained for pairwise comparisons between quercetin-treated M0 and M1 cells and their respective 
controls; (D), (E) Twenty PL species with higher VIP values i.e. higher importance to PLS-DA 
discrimination. 
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Univariate analysis of variations in individual lipid species corroborated the results of 
multivariate analysis. The volcano plots in Figure 35A,B show the variables with higher 
magnitude of variation (|ES|>0.8) in quercetin-treated M0 or M1 macrophages, relatively to 
respective controls. Then, for a clearer visualization of the most prominent changes, the top-20 
varying species in each condition (M0+Quercetin; M1+Quercetin) were displayed in the form 
of a heatmap, organized by PL classes (Figure 35C). 
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Figure 35 - (A) and (B) Volcano Plots representing the PL species with large magnitude (|ES|>0.8) in M0 and M1pre-
polarized macrophages, relatively to respective controls. The 20 species with the highest |ES| are highlighted in green 
squares.(C) Heatmap representing the top-20 varying species in quercetin treated M0 macrophages (M0+Que) and 
quercetin-treated pre—polarized cells (M1+Que), color coded according according to the percentage of  variation 
relatively to controls. 
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A first observation is that most top-20 species varied in the same direction in response 
to quercetin, independently of macrophage initial polarization state. There were however a few 
exceptions, namely in 3 plasmalogens (PC(O-42:4)/PC(P-42:3), PE(O-38:6)/PE(P-38:5) and 
PE(O-40:6)/PE(P-40:5)), PI(40:5), 2 SM species (d38:1 and d40:2). Considering all PL 
species with |ES|>0.8, the degree of similarity between M0 and M1 responses to quercetin was 
74%, while only 26% of alterations differed (Figure 36A). 
 
Secondly, the variations within each class should be noted. LPC, LPE and PC species 
mostly increased with quercetin treatment, except for PC(38:7), which showed lower levels in 
treated cells. On the other hand, PE species decreased, while plasmanyl/plasmenyl PEs 
showed species-dependent alterations. PI, PS and SM species were also predominantly 
decreased, although increases were noted for PS(38:5), SM(d38:1) and SM(d40:2) in treated 
M0 macrophages. 
As we are especially interested in revealing the PL changes putatively related to 
quercetin’s anti-inflammatory activity, we have then focused on the changes that were 
common to quercetin-treatment of pre-polarized M1 macrophages and M2 polarization. The 
44%
30%
26%
M0+Que vs. M1+Que
Common Increases
Common Decreases
Different variations
23%
19%
58%
M1+Que vs. M2
Common Increases
Common Decreases
Different variations
Figure 36 – Pie charts representing the % of common increases, common decreases and discrepant 
variations between PL data subsets collected for different exposure conditions. 
A B 
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degree of similarity between these conditions is displayed in Figure 36B. Out of the 42% 
species varying in the same direction in M1+Quercetin and M2 macrophages, we selected 
those that did not overlap with changes found in M1 polarization. We ended up of a list of 18 
PL species, whose levels are displayed in boxplots (Figure 37). Those showing increased 
levels relative to controls were PC(34:1), 4 choline plasmalogens, PE(O-40:6)/PE(P-40:5) and 
2 PI species (38:4 and 40:4). On the other hand, PL species decreasing in both M2 and 
quercetin-treated M1 macrophages were: PC(32:0), PE(O-36:6)/PE(P-36:5), PG(38:7), 3 PI 
species (32:1, 34:2, 38:6) and 4 PSs (34:1, 36:1, 36:4, 38:3). 
PC(30:1) PC(32:0) PC(O-28:0) PC(O-34:1)/PC(P-34:0) 
PC(O-36:1)/PC(P-36:0) PE(O-36:6)/PE(P-36:5) PE(O-40:6)/PE(P-40:5) PG(38:7) PI(32:1) 
PI(34:2) PI(38:4) PI(40:4) PS(34:1) 
PS(36:1) 
PC(O-30:0) 
PI(38:6) 
M0 
M2 
M1-CT 
M1-Que 
PS(36:4) PS(38:3) 
Figure 37 – Boxplots showing the levels of selected PL species in M0 macrophages, M2 macrophages, M1 pre-
polarized macrophages (24h LPS/IFN + 24h fresh medium) and quercetin-treated M1 cells (24h LPS/IFN + 24h 
quercetin 60 uM). The species represented were selected based on the same direction of variation in flavonoid-
treated and M2 macrophages, and the absence of overlap with changes characteristic of M1 polarization. 
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Although it is not possible to attribute individual PL variations to specific biological 
functions, some general observations can be inferred from the results described above. Several 
choline and ethanolamine plasmalogens were amongst the species commonly affected by 
quercetin and M2 polarization. These molecules are known to regulate the stability of lipid raft 
microdomains involved in cell signalling and cell communication [157], suggesting these 
processes to be involved in flavonoid-mediated lipid remodelling. Alterations in PI species 
may also reflect their role in signalling, specifically relating to PI3K activity and PI turnover. 
Notably, quercetin attenuated the production of some pro-inflammatory cytokines (IL-6 and 
TNF-α), which are under the regulation of the PI3K pathway. The decrease in some PS species 
is in line with the observed reduction in total PS levels observed in both M2 and quercetin 
treated M1 macrophages. Again, these lipids are important in cell signalling and inflammation 
[145]. They were reported to reduce TNF-α, IL-6, IL-8 and VEGF, as well, as PGE2 
production, in fibroblast-like synoviocytes from rheumatoid arthritis patients. In macrophages 
they might present a similar role; however, to the extent of our knowledge, the role of PS in 
macrophages is yet to be explored. Membrane fluidity was also likely affected by quercetin 
treatment, as suggested by changes in PC and SM species. Interestingly, however, SM 
variations were important within the response to quercetin but not within M2 polarization, 
likely reflecting membrane remodelling not related to anti-inflammatory activity.  
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III.2.4. Naringin-induced changes in macrophage phospholipidome  
Analysis of overall changes in PL classes (Figure 38A) reveals that naringin (200 µM) 
caused a few significant changes. Only the total PC level increased significantly upon 48h 
incubation of M0 macrophages with naringin. Other noticeable but not statistically significant 
changes comprised: i) an increase in total PS in macrophages incubated for 24h with LPS/IFN-
γ (M1 pre-polarized) followed by 24h exposure to the flavonoid (M1+Nar), ii) decreasing 
trends for PEs and SMs in both M0 and M1 macrophages treated with naringin. 
Total carbon length was also affected by naringin (Figure 38B). PL species with 32 
and 34 FA carbons showed a trend to decrease, whereas PL species with longer FA chains (36 
and 38 carbons) displayed an increasing trend (although not reaching statistical significance).  
The increase in PL species containing 36 and 38 carbons, together with the decrease in species 
containing 34 carbons, suggests an increased production of C18 and, possibly, C20, as well as 
a preference to group C18 with C18 or C20 in the same PL. However, when we compared the 
levels of PL species containing C18 (Figure 38C), we did not observe any significant 
changes, suggesting that naringin did not increase C18 production but rather promoted 
redistribution of C18. Nonetheless, naringin increased the levels of species containing 
arachidonic acid (AA) (Figure 34D). Increased PL species containing AA suggests an 
increased production of C20 FA, which can explain the tendency to increase species 
containing 38 carbons. AA is involved in inflammation by acting as precursor to produce 
eicosanoids, which may have both pro- and anti-inflammatory activity. Thus, we postulate that 
the increase in AA might reflect an increased AA turnover and production of eicosanoids, an 
hypothesis that requires further verification in future studies.  
Additionally, naringin affected the unsaturation degree of PL species (Figure 34E). 
Similarly to quercetin, naringin induced a decrease in MUFA and an increase in PUFA 
containing 4 or 5 double bonds. This effect was especially prominent in M0 macrophages. 
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Figure 38 - Changes in PL class and structure observed in M0 macrophages treated with naringin (200 µM) for 48h, and 
in pre-polarized M1 macrophages (24h, LPS+IFN-γ) subjected to 24h incubation with naringin (200 µM). The different 
graphs represent total amounts of (A) different PL classes, (B) PL-composing FA differing in total number of carbons, 
(C) C18 FA-containing PL species, (D) AA-containing PL species, (E) PL-composing FA differing in the number of 
double bonds. *, **, ****, Statistical significance (p<0.05, p<0.01, p<0.0001). Error bars represented as mean±S (n=5). 
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Following a similar strategy to that presented for quercetin, multivariate analysis was 
applied to the LC-MS data collected for the PL species identified across the 4 groups 
(naringin-treated M0 and pre-polarized M1 cells, together with their respective controls). The 
resulting PCA scores scatter plot is presented in Figure 39A. Although the groups compared 
were not perfectly separated, this plot clearly shows clustering trends according to 
macrophage polarization state and flavonoid treatment. Then, pairwise PLS-DA modelling 
resulted in robust discrimination between naringin treated macrophages and control groups 
(Figure 39B,C), allowing for the most important variables for such discrimination to be 
highlighted (Figure 39D,E).  
Further information on varying species was then obtained from PL quantification data 
and univariate statistical comparisons. The PL species with greater magnitude of variation 
(|ES| > 0.8) were represented in volcano plots (Figure 40A,B), and the top-20 altered species 
in each case were listed together in a heatmap, color-coded according to the percentage of 
variation relatively to controls (Figure 40C). Nine species varied upon naringin treatment in 
opposite directions depending on macrophage initial polarization state, while several other 
variations were noted in one of the conditions but not the other. Indeed, considering all 
varying species, only 44% were common between treated M0 macrophages (M0+Nar) and 
treated pre-polarized cells (M1+Nar) (Figure 41A).  
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A PCA 
PLS-DA 
Q
2
=0.90078 
B C PLS-DA 
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2
=0.68030 
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VIP Features VIP Features 
Figure 39 - Multivariate analysis of LC-MS data collected for M0 and M1 pre-polarized macrophages exposed to 
naringin (200 µM). (A) PCA scores scatter plot; (B),(C) PLS-DA scores scatter plot obtained for pairwise 
comparisons between naringin-treated M0 and M1 cells and their respective controls; (D), (E) Twenty PL species 
with higher VIP values i.e. higher importance to PLS-DA discrimination. 
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Considering the most prominent variations within each PL class (Figure 40C), 
naringin effects may be summarized as: i) decreased/increased LPE species in M0/M1 
macrophages, respectively; ii) increased levels of several PC species in treated M0 
macrophages, while the opposite trend is seen in treated M1 macrophages; iii) consistent 
decreases in several PE species, in both M0 and M1 macrophages; iv) decreasing trends for a 
few PG, PI and SM species, except for PG(42:10); v) consistent increases in PS species, 
especially upon treatment of pre-polarised macrophages.  
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Figure 40 - (A) and (B) Volcano Plots representing the PL species with large magnitude (|ES|>0.8) in M0 and M1pre-
polarized macrophages, relatively to respective controls. The 20 species with the highest |ES| are highlighted in green 
squares.(C) Heatmap representing the top-20 varying species in naringin treated M0 macrophages (M0+Nar) and 
naringin-treated pre—polarized cells (M1+Nar), color coded according according to the percentage of  variation 
relatively to controls. 
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Comparing PL variations in naringin-treated pre-polarized M1 macrophages with those 
induced upon M2 polarization, we found only 18% similarity (Figure 41B). This indicates 
that, in spite of naringin’s anti-inflammatory activity (assessed by the ability to attenuate pro-
inflammatory cytokines), the modulation of cellular PLs by this flavonoid greatly differed 
from PL remodelling induced by IL-4/IL-13 (M2) stimulation. Indeed, after excluding the 
changes shared with M1 polarization, only 3 species were found to represent possible M2-like 
lipid markers. These were PC (32:0), PE(O-36:6)/PE(P-36:5) and PI(38:6), which decreased in 
M2 vs. M0 macrophages, as well as in naringin-treated M1 cells vs. M1 controls (Figure 42).  
PC(32:0) PE(O-36:6)/PE(P-36:5) PI(38:6) 
M0 
M2 
M1-CT 
M1-Que 
Figure 42 - Boxplots showing the levels of selected PL species in M0 macrophages, M2 
macrophages, M1 pre-polarized macrophages (24h LPS/IFN + 24h fresh medium) and naringin-
treated M1 cells (24h LPS/IFN + 24h naringin 200 uM). The species represented were selected 
based on the same direction of variation in flavonoid-treated and M2 macrophages, and the absence 
of overlap with changes characteristic of M1 polarization. 
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25%56%
M0+Nar vs. M1+Nar
Common Increases
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Different variations
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11%
82%
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Different variations
Figure 41 - Pie charts representing the % of common increases, common decreases and discrepant 
variations between PL data subsets collected for different exposure conditions. 
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III.2.5. Naringenin-induced changes in macrophage phospholipidome  
Following the trend observed for the other flavonoids, macrophage exposure to 
naringenin caused a significant increase in total PC levels (Figure 43A). On the other hand, 
total PE showed a significant decrease in treated M0 macrophages, while displaying the 
opposite trend in pre-polarized M1 macrophages. The apparent changes in other PL classes did 
not reach statistical significance. In regard to PL total FA chain length, there were no 
statistically significant changes, although species containing 34 or 36 carbons tended to 
decrease and those containing 38 carbons tended to increase, especially in treated M0 
macrophages (Figure 43B). Analysis of PL containing C18 FAs and arachidonic acid (AA) 
further shows their increased levels in naringin-treated M0 macrophages (Figure 43C,D). As 
for FA unsaturation degree, the only significant change was a decrease in saturated species in 
naringenin-treated M0 macrophages (Figure 43E). 
The multivariate analysis results obtained for naringenin-treated macrophages and their 
respective controls are shown in Figure 40. The PCA scores scatter plot (Figure 44A) shows 
that PC1 separates samples according to their initial polarization state, whereas the effect of 
naringenin is noted along PC2. PLS-DA scores plots show very good discrimination (Q2>0.9) 
between naringenin-treated macrophages, either in the M0 or M1 state, and their respective 
controls (Figure 44B,C). The PL species with higher importance for this discriminant ability 
are highlighted in Figure 44D,E and were confirmed through quantitative analysis of 
variations (Figure 45). Among the top-20 varying species in naringenin-treated M0 or M1 
pre-polarized cells, PC and PE species are clearly dominant (Figure 45C), suggesting major 
remodelling of cell membranes. Regarding the influence of macrophages initial polarization 
state towards the response to naringenin, 5 of the most relevant variations followed opposite 
directions. Overall, 57% of naringenin-related changes were commonly produced in M0 and 
M1 macrophages (Figure 46A). 
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Figure 43 - Changes in PL class and structure observed in M0 macrophages treated with naringenin (100 µM) for 48h, and in 
pre-polarized M1 macrophages (24h, LPS+IFN-γ) subjected to 24h incubation with naringenin (100 µM). The different graphs 
represent total amounts of (A) different PL classes, (B) PL-composing FA differing in total number of carbons, (C) C18 FA-
containing PL species, (D) AA-containing PL species, (E) PL-composing FA differing in the number of double bonds. *, **, 
****, Statistical significance (p<0.05, p<0.01, p<0.0001). Error bars represented as mean±S (n=5). 
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Figure 44 - Multivariate analysis of M0 and M1-like macrophages exposed to naringenin. (A) PCA scores for M0 
and M1-like macrophages exposed to naringenin, and their respective controls. (B) PLS-DA scores for M0 
macrophages exposed to naringenin for 48h, with a Q2 of 0.90078. (D) PLS-DA scores for M1 macrophages 
exposed to naringenin with a Q2 of 0.68030. (E) VIP scores from the 20 PL species with the highest VIP value in 
exposed M0 macrophages. (F) VIP scores from the 20 PL species with the highest VIP value in exposed M1-like 
macrophages. In VIP scores plot, red represents an increase, while green represents a decrease. 
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The degree of similarity between the impact of naringenin on M1 pre-polarized 
macrophages and that of canonical M2 polarization was 30% (Figure 46B). Taking a closer 
look at those variations and excluding the ones showing the same direction upon pro-
inflammatory M1 stimulation, 13 species were highlighted (Figure 47). Those showing 
increased levels relative to controls were: PC(30:1), 2 ethanolamine plasmalogens (PE(O-
36:5)/PE(P-36:4), PE(O-36:6)/PE(P-36:5)) and 2 PI (40:4, 40:6). On the other hand, PL 
species decreasing in both M2 and naringenin-treated M1 macrophages were: PC(32:0), 2 
ethanolamine plasmalogens (PE(O-40:7)/PE(P-40:6), PE(O-42:7)/PE(P-42:6)), 2 PG (38:4, 
42:10) and 3 PS (43:1, 36:1, 36:2). Again, these changes suggest cellular modifications at the 
level of membrane properties, signalling lipids and lipid raft microdomains. 
Figure 45 - (A) and (B) Volcano Plots representing the PL species with large magnitude (|ES|>0.8) in M0 
and M1pre-polarized macrophages, relatively to respective controls. The 20 species with the highest |ES| are 
highlighted in green squares.(C) Heatmap representing the top-20 varying species in naringenin treated M0 
macrophages (M0+Ngn) and naringenin-treated pre—polarized cells (M1+Ngn), color coded according to the 
percentage of  variation relatively to controls. 
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Figure 47 - Boxplots showing the levels of selected PL species in M0 macrophages, M2 macrophages, 
M1 pre-polarized macrophages (24h LPS/IFN + 24h fresh medium) and naringenin-treated M1 cells (24h 
LPS/IFN + 24h naringenin 100 uM). The species represented were selected based on the same direction 
of variation in flavonoid-treated and M2 macrophages, and the absence of overlap with changes 
characteristic of M1 polarization. 
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Figure 46 - Pie charts representing the % of common increases, common decreases and discrepant 
variations between PL data subsets collected for different exposure conditions. 
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III.2.6. Comparison of the lipidomic changes induced by the three flavonoids  
As described in the previous sections, the three flavonoids tested (quercetin, naringin 
and naringenin) had an extensive impact on the phospholipidome of human THP-1 derived 
macrophages. This section is now aimed at comparing the main alterations induced by these 
compounds upon 24h treatment of pre-polarized M1 macrophages. Figure 48 shows a 
heatmap summarizing the species with highest magnitude of variation (top-20 varying species 
in each exposure condition).  
Interestingly, several features common to the three flavonoids could be highlighted: the 
top-varying LPC, LPE and PG species increased with all three flavonoids, while some choline 
plasmalogens and several SM species decreased, although less markedly in naringin-treated 
cells. 
On the other hand, the modulation of other PL species was clearly flavonoid-
dependent. This was the case of most diacyl PC. In particular, it is interesting to note that, 
within this class, PC with 30, 32 or 34 FA carbons varied similarly for quercetin and 
naringenin exposures, while the variation in PC with 38 or 40 FA carbons and 6/7 
unsaturations was shared by quercetin and naringin. Moreover, two diacyl PC species varied 
similarly in all treatments: PC(32:0) decreased while PC(34:4) increased, both variations being 
more prominent in naringenin-treated cells. Regarding PE species (diacyl and ethanolamine 
plasmalogens), the variations were not only flavonoid-dependent, as no general trend could be 
noted within the class (some species increased and others decreased). There is still to notice 
the modulation of PI species (decreased with quercetin and naringin, increased with 
naringenin), and of PS species (decreased with quercetin, increased with naringin and not 
varying in naringenin-treated cells).  
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Figure 48 – Heatmap representing the top-20 varying species in quercetin, naringin and naringenin 
pre—polarized cells (M1+Que, M1+Nar and M1+Ngn, respectively), color coded according to the 
percentage of variation relatively to control. 
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By extending the comparison to all species showing large magnitude of variation 
(|ES|> 0.8), we could additionally get a more general view on the degree of similarity between 
flavonoids (Figure 49). Quercetin and naringenin produced the most similar impact (58% 
common variations), while in the other pairwise comparisons (quercetin vs. naringin, naringin 
vs. naringenin) the degree of similarity was around 40%.  
 
Finally, we have looked for species that varied commonly between all M1 flavonoid-
treated macrophages and M2-polarized (anti-inflammatory) macrophages, while showing 
opposite or no variation upon M1 (pro-inflammatory) polarization. Interestingly, only two 
species (with |ES| > 0.8) obeyed these criteria: PC(32:0) and PE(O-36:6)/PE(P-36:5). Their 
boxplot representations are shown in Figure 50. In both cases, their levels decreased in M2 
macrophages (compared to M0), increased upon M1 polarization (M1-CT vs. M0) and then 
decreased upon flavonoid treatments, suggesting a relation to anti-inflammatory activity. 
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Figure 49 – Pie charts representing the % of common increases, common decreases and discrepant variations 
between PL data subsets collected for different exposure conditions. 
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PC(32:0) PE(O-36:6)/PE(P-36:5) 
Figure 50 – PL species that varied commonly between flavonoid-treated M1 pre-polarized macrophages 
and M2-polarized (anti-inflammatory) macrophages, while showing opposite or no variation upon M1 (pro-
inflammatory) polarization. 
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IV.  Conclusions and Future Work  
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The HILIC-LC-MS approach applied to human THP-1 derived macrophage lipid 
extracts enabled the identification and relative quantification of 147 phospholipid (PL) species 
belonging to 8 different classes: phosphatidylcholines (PC), including diacyl and alkyl-acyl 
PC, phosphatidylethanolamines (PE), including diacyl and alkyl-acyl PE, lyso-
phosphatidylcholines (LPC), lyso-phosphatidylethanolamines (LPE), phosphatidylglycerols 
(PG), phosphatidylinositols (PI), phosphatidylserines (PS), and sphingomyelins (SM).  Then, 
multivariate and univariate analysis of LC-MS data enabled the changes in the levels of these 
species to be characterized under different conditions, namely under M1 and M2 canonical 
polarization, and upon treatment with three flavonoids (quercetin, naringin and naringenin). 
Although these compounds have well-known anti-inflammatory activity, to our knowledge, 
their effects on macrophage lipidome had never been reported, and were here presented and 
discussed for the first time. 
As expected, the three flavonoids were found to attenuate the production of important 
pro-inflammatory cytokines by M1 macrophages, at 24h incubation time and specific 
concentrations (maximal doses not decreasing cell viability). Moreover, naringenin increased 
the levels of an anti-inflammatory mediator (CCL-17), suggesting its pro-resolving activity.  
Regarding lipidomic results, all flavonoids were seen to have a pronounced impact on 
the macrophage phospholipidome, causing large magnitude variations in 47-77% of all 
identified PL species. The top-20 varying species were highlighted in each case and found to 
belong predominantly to: i) PC, PE, PI and SM in the case of quercetin, ii) PC, PE and PS in 
the case of naringin, iii) PC and PE in the case of naringenin. These alterations suggested 
flavonoid-induced modulation of cell membrane composition and fluidity (mainly affecting 
PC, PE and SM), interference with cell signalling pathways (mainly involving PI, PS and 
plasmalogens), and/or antioxidant activity (possibly related to plasmalogens). 
Notably, the observed effects were dependent on macrophage initial polarization state, 
at different extents depending on the flavonoid considered. In particular, the degrees of 
similarity between the responses of uncommitted M0 macrophages and M1 pre-polarized 
macrophages to each flavonoid were 74% for quercetin, 44% for naringin and 57% for 
naringenin. This result was not unexpected given that macrophage activation has been shown 
98 
 
by us and others to deeply affect cellular lipids. Hence, it is likely that subsequent flavonoid 
effects depend on the initial cellular composition. On the other hand, the fact that many 
variations were independent of the initial polarization state underscored strong flavonoid 
specific effects, indicating flavonoid action to be effective even after a pro-inflammatory 
stimulus. 
Then, focusing on PL species that varied commonly between flavonoid-treated M1 
pre-polarized macrophages and M2-polarized (anti-inflammatory) macrophages (while 
showing opposite or no variation upon M1 polarization), a subset of potential markers of anti-
inflammatory activity was highlighted for each flavonoid: 18 species in the case of quercetin, 
3 in the case of naringin and 13 in the case of naringenin. It should be noted, however, that 
although canonical M2 polarization may serve as reference to assess changes related to anti-
inflammatory activity, this may be viewed as a simplistic and limited approach, as other 
flavonoid-induced changes, not found in M2 macrophages, may also be linked to attenuation 
and/or resolution of macrophage-mediated inflammatory responses.  
Furthermore, by comparing the most prominent effects of the three flavonoids on M1 
pre-polarized macrophages, it was possible to conclude that flavonoid-mediated lipid 
remodelling was generally characterized by increases in LPC, LPE and PG species, 
accompanied by decreases in choline plasmalogens and SM species, whereas the modulation 
of other PL species was clearly flavonoid-dependent. Overall, quercetin and naringenin shared 
the greatest similarity. Finally, two species emerged as potential anti-inflammatory lipid 
markers of flavonoid activity: PC(32:0) and PE(O-36:6)/PE(P-36:5), both decreased in 
response to either M2 polarization and flavonoid treatment. Their anti-inflammatory activity 
and relevance to macrophage biology (e.g. membrane fluidity, production of cytokines, 
phagocytosis) should be explored in future studies.  
One of the limitations of this study was that flavonoid effects were not evaluated at 
different concentrations and exposure times. Given that macrophages are highly plastic cells, it 
would be useful to perform time course experiments at different flavonoid doses. Future 
studies should also include the targeted analysis of eicosanoids (especially relevant in the 
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context of inflammation), and assessment of key proteins involved in lipid metabolism, to help 
clarifying the biochemical mechanisms underlying the changes observed in this work. 
Overall, we expect that these results may open new research avenues towards a greater 
understanding of the interplay between flavonoid-induced PL modulation and the pro-/anti-
inflammatory activity of macrophages. 
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